10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2015

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 0-28000

PRGX Global, Inc.

(Exact name of registrant as specified in its charter)

Georgia	58-2213805
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
600 Galleria Parkway	30339-5986
Suite 100	(Zip Code)
Atlanta, Georgia
(Address of principal executive offices)

Registrant’s telephone number, including area code: (770) 779-3900

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check One):

¨  Large accelerated filer	ý	Accelerated filer
¨  Non-accelerated filer     (Do not check if a smaller reporting company)	¨	Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  ý

Common shares of the registrant outstanding at April 30, 2015 were 25,659,719.

PRGX GLOBAL, INC.

FORM 10-Q

For the Quarter Ended March 31, 2015

INDEX

	Page No.
Part I. Financial Information
Item 1. Financial Statements (Unaudited)	1
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2015 and 2014	1
Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2015 and 2014	1
Condensed Consolidated Balance Sheets as of March 31, 2015 and December 31, 2014	2
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2015 and 2014	3
Notes to Condensed Consolidated Financial Statements	4
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	11
Item 3. Quantitative and Qualitative Disclosures About Market Risk	22
Item 4. Controls and Procedures	23
Part II. Other Information
Item 1. Legal Proceedings	24
Item 1A. Risk Factors	24
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	24
Item 3. Defaults Upon Senior Securities	24
Item 4. Mine Safety Disclosures	24
Item 5. Other Information	24
Item 6. Exhibits	25
Signatures	26

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

PRGX GLOBAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share data)

	Three Months Ended March 31,
	2015			2014
Revenue	$	33,132		$	37,901
Operating expenses:
Cost of revenue	23,778			28,832
Selling, general and administrative expenses	8,169			9,976
Depreciation of property and equipment	1,292			1,682
Amortization of intangible assets	746			903
Total operating expenses	33,985			41,393
Operating loss	(853		)	(3,492		)
Foreign currency transaction (gains) losses on short-term intercompany balances	1,692			15
Interest expense (income), net	(42		)	54
Loss before income taxes	(2,503		)	(3,561		)
Income tax expense	455			113
Net loss	$	(2,958	)	$	(3,674	)
Basic earnings (loss) per common share (Note B)	$	(0.11	)	$	(0.12	)
Diluted earnings (loss) per common share (Note B)	$	(0.11	)	$	(0.12	)
Weighted-average common shares outstanding (Note B):
Basic	26,394			30,159
Diluted	26,394			30,159

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

(In thousands)

	Three Months Ended March 31,
	2015			2014
Net loss	$	(2,958	)	$	(3,674	)
Foreign currency translation adjustments	(31		)	(70		)
Comprehensive loss	$	(2,989	)	$	(3,744	)

See accompanying Notes to Condensed Consolidated Financial Statements.

1

PRGX GLOBAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share data)

	March 31, 2015			December 31, 2014
ASSETS
Current assets:
Cash and cash equivalents (Note E)	$	23,388		$	25,735
Restricted cash	107			53
Receivables:
Contract receivables, less allowances of $2,077 in 2015 and $2,243 in 2014:
Billed	27,646			32,373
Unbilled	1,027			2,809
	28,673			35,182
Employee advances and miscellaneous receivables, less allowances of $626 in 2015 and $692 in 2014	1,854			1,993
Total receivables	30,527			37,175
Prepaid expenses and other current assets	2,842			3,421
Total current assets	56,864			66,384
Property and equipment	56,477			56,174
Less accumulated depreciation and amortization	(44,632		)	(43,954		)
Property and equipment, net	11,845			12,220
Goodwill	12,994			13,036
Intangible assets, less accumulated amortization of $34,306 in 2015 and $33,973 in 2014	8,651			9,439
Noncurrent portion of unbilled receivables	582			1,196
Other assets	500			507
Total assets	$	91,436		$	102,782
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	6,185		$	7,397
Accrued payroll and related expenses	12,782			15,415
Refund liabilities	5,009			5,393
Deferred revenue	2,301			2,173
Other current liabilities	239			—
Total current liabilities	26,516			30,378
Noncurrent refund liabilities	749			857
Other long-term liabilities	568			561
Total liabilities	27,833			31,796
Commitments and contingencies (Note H)
Shareholders’ equity (Note B):
Common stock, no par value; $.01 stated value per share. Authorized 50,000,000 shares; 25,654,992 shares issued and outstanding at March 31, 2015 and 26,762,861 shares issued and outstanding at December 31, 2014	257			268
Additional paid-in capital	585,684			590,067
Accumulated deficit	(523,870		)	(520,912		)
Accumulated other comprehensive income	1,532			1,563
Total shareholders’ equity	63,603			70,986
Total liabilities and shareholders’ equity	$	91,436		$	102,782

See accompanying Notes to Condensed Consolidated Financial Statements.

2

PRGX GLOBAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

	Three Months Ended March 31,
	2015			2014
Cash flows from operating activities:
Net loss	$	(2,958	)	$	(3,674	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,038			2,585
Amortization of deferred loan costs	—			16
Stock-based compensation expense	1,132			1,021
Deferred income taxes	216			(209		)
Foreign currency transaction (gains) losses on short-term intercompany balances	1,692			15
Changes in operating assets and liabilities:
Restricted cash	(54		)	(69		)
Billed receivables	3,688			3,055
Unbilled receivables	2,396			4,177
Prepaid expenses and other current assets	647			706
Other assets	27			1
Accounts payable and accrued expenses	(963		)	(3,192		)
Accrued payroll and related expenses	(2,148		)	(1,453		)
Refund liabilities	(492		)	(647		)
Deferred revenue	170			309
Noncurrent compensation obligations	—			184
Other long-term liabilities	33			87
Net cash provided by operating activities	5,424			2,912
Cash flows from investing activities:
Purchases of property and equipment, net of disposal proceeds	(1,116		)	(844		)
Net cash used in investing activities	(1,116		)	(844		)
Cash flows from financing activities:
Payment of deferred loan costs	—			(80		)
Restricted stock repurchased from employees for withholding taxes	(51		)	(5		)
Proceeds from option exercises	45			2,183
Payments of deferred acquisition consideration	—			(1,978		)
Repurchase of common stock	(5,488		)	(40		)
Net cash (used in) provided by financing activities	(5,494		)	80
Effect of exchange rates on cash and cash equivalents	(1,161		)	(151		)
Net increase (decrease) in cash and cash equivalents	(2,347		)	1,997
Cash and cash equivalents at beginning of period	25,735			43,700
Cash and cash equivalents at end of period	$	23,388		$	45,697
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	$	14		$	19
Cash paid during the period for income taxes, net of refunds received	$	188		$	948

See accompanying Notes to Condensed Consolidated Financial Statements.

3

PRGX GLOBAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note A – Basis of Presentation

The accompanying Condensed Consolidated Financial Statements (Unaudited) of PRGX Global, Inc. and its wholly owned subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three-month period ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015.

Except as otherwise indicated or unless the context otherwise requires, “PRGX,” “we,” “us,” “our” and the “Company” refer to PRGX Global, Inc. and its subsidiaries. For further information, refer to the Consolidated Financial Statements and Footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2014.

Beginning with the second quarter of 2014, we reclassified certain information technology expenses within our Recovery Audit Services — Americas segment from Selling, General and Administrative expenses to Cost of Revenue to better reflect the nature of the work performed. We have revised the presentation of our Selling, General and Administrative expenses and Cost of Revenue for all relevant prior periods.

New Accounting Standards

A summary of the new accounting standards issued by the Financial Accounting Standards Board (“FASB”) and included in the Accounting Standards Codification (“ASC”) that apply to PRGX is set forth below:

FASB ASC Update No. 2015-03. In April 2015, the FASB issued Accounting Standards Update No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30) (“ASU 2015-03”). ASU 2015-03 simplifies presentation of debt issuance costs by requiring that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for annual periods beginning after December 15, 2015 with early adoption permitted. The guidance also requires retrospective application to all prior periods presented. We are currently evaluating of the impact of ASU 2015-03 on our consolidated financial statements.

FASB ASC Update No. 2014-15. In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40) (“ASU 2014-15”). ASU 2014-15 provides guidance on management's responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and related disclosure requirements. ASU 2014-15 is effective for annual periods beginning after December 15, 2016 with early adoption permitted. We do not expect the adoption of ASU 2014-15 to have a material impact on our consolidated financial statements.

FASB ASC Update No. 2014-09. In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in Revenue Recognition (Topic 605), and requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the transferring entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 allows for adoption using either of two methods; retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of application recognized at the date of initial adoption. It is effective for annual periods beginning after December 15, 2016. Early adoption is not permitted. We are currently evaluating the impact of ASU 2014-09 on our consolidated financial statements.

4

PRGX GLOBAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Note B – Earnings (Loss) Per Common Share

The following tables set forth the computations of basic and diluted earnings (loss) per common share for the three months ended March 31, 2015 and 2014 (in thousands, except per share data):

	Three Months Ended March 31,
Basic earnings (loss) per common share:	2015			2014
Numerator:
Net loss	$	(2,958	)	$	(3,674	)
Denominator:
Weighted-average common shares outstanding	26,394			30,159
Basic earnings (loss) per common share	$	(0.11	)	$	(0.12	)

	Three Months Ended March 31,
Diluted earnings (loss) per common share:	2015			2014
Numerator:
Net loss	$	(2,958	)	$	(3,674	)
Denominator:
Weighted-average common shares outstanding	26,394			30,159
Incremental shares from stock-based compensation plans	—			—
Denominator for diluted earnings (loss) per common share	26,394			30,159
Diluted earnings (loss) per common share	$	(0.11	)	$	(0.12	)

For the three months ended March 31, 2015, weighted-average common shares outstanding excludes from the computation of diluted earnings (loss) per common share antidilutive shares underlying options that totaled 3.3 million shares and antidilutive Performance Units issuable under the Company's 2006 Management Incentive Plan that totaled less than 0.1 million shares. For the three months ended March 31, 2014, weighted-average common shares outstanding excludes from the computation of diluted earnings (loss) per common share antidilutive shares underlying options that totaled 2.4 million shares and antidilutive Performance Units related to the Company's 2006 Management Incentive Plan that totaled less than 0.1 million shares. As a result of the net loss for the three months ended March 31, 2015 and March 31, 2014, all shares underlying stock options and Performance Units were considered antidilutive. The number of common shares we used in the basic and diluted earnings (loss) per common share computations include nonvested restricted shares of 0.5 million and 0.7 million for the three months ended March 31, 2015 and 2014, respectively, and nonvested restricted share units that we consider to be participating securities of 1.4 million and 0.2 million for the three months ended March 31, 2015 and 2014, respectively.

We repurchased 1,129,932 shares of our common stock during the three months ended March 31, 2015 for $5.5 million, and 6,700 shares of our common stock during the three months ended March 31, 2014 for less than $0.1 million.

Pursuant to exercises of outstanding stock options, we issued 12,863 shares of our common stock having a value of less than $0.1 million in the three months ended March 31, 2015 and 563,514 shares of our common stock having a value of $2.2 million in the three months ended March 31, 2014. Stock option exercises during the three-month period ended March 31, 2014 primarily consisted of exercises by a former executive officer of the Company.

In partial satisfaction of a business acquisition obligation, we issued 187,620 shares of our common stock having a value of $1.3 million in the three months ended March 31, 2014. There were no shares issued to satisfy business acquisition obligations in the three months ended March 31, 2015.

5

PRGX GLOBAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Note C – Stock-Based Compensation

The Company currently has two stock-based compensation plans under which awards are outstanding: (1) the 2006 Management Incentive Plan (“2006 MIP”) and (2) the 2008 Equity Incentive Plan (“2008 EIP”) (collectively, the “Plans”). We describe the Plans in the Company’s Annual Report on Form 10–K for the fiscal year ended December 31, 2014. For all periods presented herein, awards outside the Plans are referred to as inducement awards.

2008 EIP Awards and Inducement Awards

Stock options granted under the 2008 EIP generally have a term of seven years and vest in equal annual increments over the vesting period, which typically is three years for employees and one year for directors. There were no stock option grants during the three months ended March 31, 2014. The following table summarizes stock option grants during the three months ended March 31, 2015:

Grantee Type	# of Options Granted	Vesting Period	Weighted Average Exercise Price		Weighted Average Grant Date Fair Value
2015
Director	2,849	1 year or less	$	4.07	$	0.97
Director	8,546	3 years	$	4.07	$	1.46
Employee inducements (1)	75,000	3 years	$	5.81	$	1.45

(1) The Company granted non-qualified stock options outside its existing stock-based compensation plans in the first quarter of 2015 to two employees in connection with the employees joining the Company.

Nonvested stock awards, including both restricted stock and restricted stock units, granted under the 2008 EIP generally are nontransferable until vesting and the holders are entitled to receive dividends with respect to the nonvested shares. Prior to vesting, the grantees of restricted stock are entitled to vote the shares, but the grantees of restricted stock units are not entitled to vote the shares. Generally, nonvested stock awards with time-based vesting criteria vest in equal annual increments over the vesting period, which typically is three years for employees and one year for directors. There were no nonvested stock awards (restricted stock and restricted stock units) granted during the three months ended March 31, 2014. The following table summarizes nonvested stock awards granted during the three months ended March 31, 2015:

Grantee Type	# of Shares Granted	Vesting Period	Weighted Average Grant Date Fair Value
2015
Director	2,849	1 year or less	$	4.07
Director	8,546	3 years	$	4.07
Employee group (1)	1,325,000	2 years	$	4.00
Employee inducements (2)	10,000	3 years	$	5.29

(1) The Company granted nonvested performance-based stock awards (restricted stock units) in the first quarter of 2015 to eight executive officers.

(2) The Company granted nonvested stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2015 to two employees in connection with the employees joining the Company.

2006 MIP Performance Units

On June 19, 2012, seven executive officers of the Company were granted 154,264 Performance Units under the 2006 MIP, comprising all of the then remaining available awards under the 2006 MIP. The awards had an aggregate grant date fair value of $1.2 million and vest ratably over three years. Upon vesting, the Performance Units will be settled by the issuance of Company common stock equal to 60% of the number of Performance Units being settled and the payment of cash in an amount equal to 40% of the fair market value of that number of shares of common stock equal to the number of Performance Units being settled. During the three months endedMarch 31, 2015, an aggregate of 6,200 Performance Units were settled, which resulted in the issuance of 3,720 shares of common stock and cash payments of less than $0.1 million. There were no Performance Units settled during the three months endedMarch 31, 2014. Since the June 19, 2012 grant date to March 31, 2015, an aggregate of 127,410 Performance Units were settled by two current executive officers and four former executive officers, and 16,524 Performance Units were forfeited by one former executive officer and currently are available to be granted.

6

PRGX GLOBAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Such settlements resulted in the issuance of 73,158 shares of common stock and cash payments totaling $0.3 million. As of March 31, 2015, a total of 10,330 Performance Units were outstanding, none of which were vested.

Performance-Based Restricted Stock Units

On March 30, 2015, eight executive officers of the Company were granted 1,325,000 performance-based restricted stock units (“PBUs”) under the 2008 EIP. Upon vesting, the PBUs will be settled by the issuance of Company common stock equal to 50% of the number of PBUs being settled and the payment of cash in an amount equal to 50% of the fair market value of that number of shares of common stock equal to the number of PBUs being settled. The PBUs vest and become payable based on the cumulative adjusted EBITDA that the Company (excluding the Healthcare Claims Recovery Audit business) achieves for the two-year performance period ending December 31, 2016. At the threshold performance level, 35% of the PBUs will become vested and payable; at the target performance level, 100% of the PBUs will become vested and payable; and at the maximum performance level, 200% of the PBUs will become vested and payable. If performance falls between the stated performance levels, the percentage of PBUs that shall become vested and payable will be based on straight line interpolation between such stated performance levels (although the PBUs may not become vested and payable for more than 200% of the PBUs and no PBUs shall become vested and payable if performance does not equal or exceed the threshold performance level).

Selling, general and administrative expenses for the three months ended March 31, 2015 and 2014 include $1.1 million and $1.0 million, respectively, related to stock-based compensation charges. At March 31, 2015, there was $14.9 million of unrecognized stock-based compensation expense related to stock options, restricted stock awards, restricted stock unit awards, and Performance Unit awards which we expect to recognize over a weighted-average period of 1.8 years. The unrecognized stock-based compensation expense related to restricted stock unit awards with performance vesting criteria is based on our estimate of both the number of shares of the Company's common stock that will ultimately be issued and cash payments that will be made when the restricted stock units are settled.

Note D – Operating Segments and Related Information

We conduct our operations through the following four reportable segments:

Recovery Audit Services – Americas represents recovery audit services (other than Healthcare Claims Recovery Audit services) provided in the United States of America (“U.S.”), Canada and Latin America.

Recovery Audit Services – Europe/Asia-Pacific represents recovery audit services (other than Healthcare Claims Recovery Audit services) provided in Europe, Asia and the Pacific region.

Adjacent Services represents data transformation, data analytics and associated advisory services.

Healthcare Claims Recovery Audit Services represents recovery audit services for healthcare claims, which consist primarily of services provided under subcontracts related to the Medicare Recovery Audit Contractor program.

Additionally, Corporate Support includes the unallocated portion of corporate selling, general and administrative expenses not specifically attributable to the four reportable segments.

We evaluate the performance of our reportable segments based upon revenue and measures of profit or loss we refer to as EBITDA and Adjusted EBITDA. We define Adjusted EBITDA as earnings from continuing operations before interest and taxes (“EBIT”), adjusted for depreciation and amortization (“EBITDA”), and then further adjusted for unusual and other significant items that management views as distorting the operating results of the various segments from period to period. Such adjustments include restructuring charges, stock-based compensation, bargain purchase gains, acquisition-related charges and benefits (acquisition transaction costs, acquisition obligations classified as compensation, and fair value adjustments to acquisition-related contingent consideration), tangible and intangible asset impairment charges, certain litigation costs and litigation settlements, certain severance charges and foreign currency transaction gains and losses on short-term intercompany balances viewed by management as individually or collectively significant. We do not have any inter-segment revenue.

7

PRGX GLOBAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Segment information for the three months ended March 31, 2015 and 2014 (in thousands) is as follows:

	Recovery Audit Services – Americas		Recovery Audit Services – Europe/Asia- Pacific			Adjacent Services			Healthcare Claims Recovery Audit Services			Corporate Support			Total
Three Months Ended March 31, 2015
Revenue	$	22,417	$	9,305		$	1,263		$	147		$	—		$	33,132
Net loss															$	(2,958	)
Income tax expense															455
Interest expense (income), net															(42		)
EBIT	$	4,078	$	(442	)	$	(885	)	$	(702	)	$	(4,594	)	(2,545		)
Depreciation of property and equipment	969		153			157			13			—			1,292
Amortization of intangible assets	441		273			32			—			—			746
EBITDA	5,488		(16		)	(696		)	(689		)	(4,594		)	(507		)
Foreign currency transaction (gains) losses on short-term intercompany balances	437		1,318			—			—			(63		)	1,692
Transformation severance and related expenses	56		65			16			—			9			146
Stock-based compensation	—		—			—			—			1,132			1,132
Adjusted EBITDA	$	5,981	$	1,367		$	(680	)	$	(689	)	$	(3,516	)	$	2,463

	Recovery Audit Services – Americas		Recovery Audit Services – Europe/Asia- Pacific			Adjacent Services			Healthcare Claims Recovery Audit Services			Corporate Support			Total
Three Months Ended March 31, 2014
Revenue	$	24,798	$	9,702		$	2,283		$	1,118		$	—		$	37,901
Net loss															$	(3,674	)
Income tax expense															113
Interest expense (income), net															54
EBIT	$	4,084	$	101		$	(1,574	)	$	(2,006	)	$	(4,112	)	(3,507		)
Depreciation of property and equipment	1,256		146			160			120			—			1,682
Amortization of intangible assets	500		307			96			—			—			903
EBITDA	5,840		554			(1,318		)	(1,886		)	(4,112		)	(922		)
Foreign currency transaction (gains) losses on short-term intercompany balances	110		(73		)	—			—			(22		)	15
Acquisition-related charges (benefits)	—		—			19			—			—			19
Transformation severance and related expenses	8		79			143			155			—			385
Stock-based compensation	—		—			—			—			1,021			1,021
Adjusted EBITDA	$	5,958	$	560		$	(1,156	)	$	(1,731	)	$	(3,113	)	$	518

8

PRGX GLOBAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Note E – Cash and Cash Equivalents

Cash and cash equivalents include all cash balances and highly liquid investments with an initial maturity of three months or less from date of purchase. We place our temporary cash investments with high credit quality financial institutions. At times, certain investments may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limit or otherwise may not be covered by FDIC insurance. Some of our cash and cash equivalents are held at banks in jurisdictions outside the U.S. that have restrictions on transferring such assets outside of these countries on a temporary or permanent basis. Such restricted net assets are not significant in comparison to our consolidated net assets.

Our cash and cash equivalents included short-term investments of approximately $6.6 million as of March 31, 2015 and $12.2 million as of December 31, 2014, of which approximately $2.9 million and $2.5 million, respectively, were held at banks outside of the United States, primarily in Brazil and Canada.

Note F – Debt

On January 19, 2010, we entered into a four-year revolving credit and term loan agreement (the “2010 Credit Agreement”) with SunTrust Bank (“SunTrust”). Subsequent modifications of the 2010 Credit Agreement were entered into with SunTrust. Most recently, on December 23, 2014, we entered into an amended and restated revolving credit agreement (the “Credit Facility”) with SunTrust. The Credit Facility, and provisions of the 2010 Credit Agreement where applicable, is guaranteed by the Company and all of its material domestic subsidiaries and secured by substantially all of the assets of the Company.

The amount available for borrowing under the Credit Facility is $20.0 million, and as of March 31, 2015 we had no outstanding borrowings. With the Credit Facility provision of a fixed applicable margin of 1.75% plus a specified index rate based on one-month LIBOR, the interest rate that would have applied at March 31, 2015 had any borrowings been outstanding was approximately 1.92%. We also must pay a commitment fee of 0.25% per annum, payable quarterly, on the unused portion of the Credit Facility.

The Credit Facility includes customary affirmative, negative, and financial covenants binding on the Company, including delivery of financial statements and other reports, maintenance of existence, and transactions with affiliates. The negative covenants limit the ability of the Company, among other things, to incur debt, incur liens, make investments, sell assets or declare or pay dividends on its capital stock. The financial covenants included in the Credit Facility, among other things, limit the amount of capital expenditures the Company can make, set forth maximum leverage and net funded debt ratios for the Company and a minimum fixed charge coverage ratio, and also require the Company to maintain minimum consolidated earnings before interest, taxes, depreciation and amortization. In addition, the Credit Facility includes customary events of default. The Company was in compliance with the covenants in its Credit Facility as of March 31, 2015.

Note G – Fair Value of Financial Instruments

We state cash equivalents at cost, which approximates fair market value. The carrying values for receivables from clients, unbilled services, accounts payable, deferred revenue and other accrued liabilities reasonably approximate fair market value due to the nature of the financial instrument and the short term maturity of these items.

We had no debt outstanding as of March 31, 2015 and December 31, 2014. We consider the factors used in determining the fair value of debt to be Level 3 inputs (significant unobservable inputs).

We had no business acquisition obligations as of March 31, 2015 and December 31, 2014. We determine the estimated fair values of business acquisition obligations based on our projections of future revenue and profits or other factors used in the calculation of the ultimate payment to be made. The discount rate that we use to value the liability is based on specific business risk, cost of capital, and other factors. We consider these factors to be Level 3 inputs (significant unobservable inputs).

Note H – Commitments and Contingencies

Legal Proceedings

We are party to a variety of legal proceedings arising in the normal course of business. While the results of these proceedings cannot be predicted with certainty, management believes that the final outcome of these proceedings will not have a material adverse effect on our financial position, results of operations or cash flows.

9

PRGX GLOBAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Note I – Income Taxes

Reported income tax expense in each period primarily results from taxes on the income of foreign subsidiaries. The effective tax rates generally differ from the expected tax rate due primarily to the Company’s deferred tax asset valuation allowance on the domestic earnings and taxes on income of foreign subsidiaries.

Significant judgment is required in evaluating our uncertain tax positions and determining our provision for income taxes. In addition, we are subject to the continuous examination of our income tax returns by the Internal Revenue Service in the U.S. and other tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes.

We apply a “more-likely-than-not” recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. We refer to GAAP for guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. In accordance with FASB ASC 740, our policy for recording interest and penalties associated with tax positions is to record such items as a component of income before income taxes. A number of years may elapse before a particular tax position is audited and finally resolved or when a tax assessment is raised. The number of years subject to tax assessments also varies by tax jurisdiction.

Note J – Subsequent Events

On April 28, 2015, the Company announced its decision to exit its Healthcare Claims Recovery Audit Services business due to the continued challenges in the Medicare RAC business and our lack of a diversified client base in that segment.

10

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

We conduct our operations through four reportable segments: Recovery Audit Services - Americas, Recovery Audit Services - Europe/Asia-Pacific, Adjacent Services and Healthcare Claims Recovery Audit Services. The Recovery Audit Services - Americas segment represents recovery audit services (other than Healthcare Claims Recovery Audit Services) we provide in the U.S., Canada and Latin America. The Recovery Audit Services - Europe/Asia-Pacific segment represents recovery audit services (other than Healthcare Claims Recovery Audit Services) we provide in Europe, Asia and the Pacific region. The Adjacent Services segment represents data transformation, data analytics and associated advisory services. The Healthcare Claims Recovery Audit Services segment represents recovery audit services that involve the identification of overpayments and underpayments made by healthcare payers to healthcare providers such as hospitals and physicians’ practices and includes services we provide as a subcontractor to three of the four prime contractors in the Medicare Recovery Audit Contractor program (the “Medicare RAC program”) of the Centers for Medicare and Medicaid Services (“CMS”). We include the unallocated portion of corporate selling, general and administrative expenses not specifically attributable to the four reportable segments in Corporate Support.

Recovery auditing is a business service focused on finding overpayments created by errors in payment transactions, such as missed or inaccurate discounts, allowances and rebates, vendor pricing errors, erroneous coding and duplicate payments. Generally, we earn our recovery audit revenue by identifying overpayments made by our clients, assisting our clients in recovering the overpayments from their vendors, and collecting a specified percentage of the recoveries from our clients as our fee. The fee percentage we earn is based on specific contracts with our clients that generally also specify: (a) time periods covered by the audit; (b) the nature and extent of services we are to provide; and (c) the client’s responsibilities to assist and cooperate with us. Clients generally recover claims by either taking credits against outstanding payables or future purchases from the relevant vendors, or receiving refund checks directly from those vendors. The manner in which a claim is recovered by a client is often dictated by industry practice. In addition, many clients establish client-specific procedural guidelines that we must satisfy prior to submitting claims for client approval. Our recovery audit business also includes contract compliance services which focus on auditing supplier billings against large and complex services, construction and licensing contracts. Such services include verification of the accuracy of third party reporting, appropriateness of allocations and other charges in cost or revenue sharing types of arrangements, adherence to contract covenants and other risk mitigation requirements and numerous other reviews and procedures to assist our clients with proper monitoring and enforcement of the obligations of their contractors. For some services we provide, such as certain of our services in our Adjacent Services segment, we earn our compensation in the form of a fixed fee, a fee per hour, or a fee per other unit of service.

We earn the vast majority of our recovery audit revenue from clients in the retail industry due to many factors, including the high volume of transactions and the complicated pricing and allowance programs typical in this industry. Changes in consumer spending associated with economic fluctuations generally impact our recovery audit revenue to a lesser degree than they affect individual retailers due to several factors, including:

• Diverse client base – our clients include a diverse mix of discounters, grocery, pharmacy, department and other stores that tend to be impacted to varying degrees by general economic fluctuations, and even in opposite directions from each other depending on their position in the market and their market segment;

• Motivation – when our clients experience a downturn, they frequently are more motivated to use our services to recover prior overpayments to make up for relatively weaker financial performance in their own business operations;

• Nature of claims – the relationship between the dollar amount of recovery audit claims identified and client purchases is non-linear. Claim volumes are generally impacted by purchase volumes, but a number of other factors may have an even more significant impact on claim volumes, including new items being purchased, changes in discount, rebate, marketing allowance and similar programs offered by vendors and changes in a client’s or a vendor’s information processing systems; and

• Timing – the client purchase data on which we perform our recovery audit services is historical data that typically reflects transactions between our clients and their vendors that took place 3 to 15 months prior to the data being provided to us for audit. As a result, we generally experience a delayed impact from economic changes that varies by client and the impact may be positive or negative depending on the individual clients’ circumstances.

While the net impact of the economic environment on our recovery audit revenue is difficult to determine or predict, we believe that for the foreseeable future, our revenue will remain at a level that will not have a significant adverse impact on our liquidity, and we have taken steps to mitigate the adverse impact of an economic downturn on our revenue and overall financial health. These steps include devoting substantial efforts to develop an improved service delivery model to enable us to more cost

11

effectively serve our clients. Further, we continue to pursue our ongoing growth strategy to expand our business beyond our core recovery audit services to retailers by growing the portion of our business that provides recovery audit services to enterprises other than retailers, such as our offerings to commercial clients; contract compliance service offerings; expansion into new industry verticals, such as oil and gas; and growth within our Adjacent Services segment.

Our Adjacent Services business targets client functional and process areas where we have established expertise, enabling us to provide services to finance and procurement executives to improve working capital, optimize purchasing leverage in vendor pricing negotiations, improve insight into product margin and true cost of goods for resale, identify and manage risks associated with vendor compliance, improve quality of vendor master data and improve visibility and diagnostics of direct and indirect spend. Our Adjacent Services also include the CIPS Sustainability Index, an Internet-based supplier sustainability assessment offered in the UK through our strategic alliance with the Chartered Institute of Purchasing & Supply (“CIPS”). As our clients’ data volumes and complexity levels continue to grow, we are using our deep data management experience to develop new actionable insight solutions, as well as to develop custom analytics and data transformation services. Taken together, our deep understanding of our clients’ procure-to-pay data and our technology-based solutions provide multiple routes to help our clients achieve greater profitability.

During 2013, auditing under our current Medicare RAC program subcontracts became subject to significant additional restrictions imposed by CMS on all Medicare recovery auditors, including deadlines for requesting medical records from providers and submitting claims and the types of claims that may be audited. These restrictions began to limit our Medicare RAC program revenue in the third quarter of 2013 and had a significant negative impact on our fourth quarter 2013 and annual 2014 Medicare RAC program revenue. For a number of reasons, including the significant uncertainties and financial risks inherent in the Medicare RAC program, we withdrew from the Medicare RAC program rebid process in February 2014. On April 28, 2015, the Company announced its decision to exit its Healthcare Claims Recovery Audit Services business due to the continued challenges in the Medicare RAC business and our lack of a diversified client base in that segment. The Company will likely incur employee termination and other exit costs as a result of this strategic decision.

Non-GAAP Financial Measures

EBIT, EBITDA and Adjusted EBITDA are all “non-GAAP financial measures” presented as supplemental measures of the Company’s performance. They are not presented in accordance with accounting principles generally accepted in the United States, or GAAP. The Company believes these measures provide additional meaningful information in evaluating its performance over time, and that the rating agencies and a number of lenders use EBITDA and similar measures for similar purposes. In addition, a measure similar to Adjusted EBITDA is used in the restrictive covenants contained in the Company’s secured credit facility. However, EBIT, EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of the Company’s results as reported under GAAP. In addition, in evaluating EBIT, EBITDA and Adjusted EBITDA, you should be aware that, as described above, the adjustments may vary from period to period and in the future the Company will incur expenses such as those used in calculating these measures. The Company’s presentation of these measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. We include a reconciliation of net loss to each of EBIT, EBITDA and Adjusted EBITDA and a calculation of Adjusted EBITDA by segment below in “–Adjusted EBITDA”.

12

Results of Operations

The following table sets forth the percentage of revenue represented by certain items in the Company’s Condensed Consolidated Statements of Operations (Unaudited) for the periods indicated:

	Three Months Ended March 31,
	2015		2014
Revenue	100.0	%	100.0	%
Operating expenses:
Cost of revenue	71.8		76.1
Selling, general and administrative expenses	24.7		26.3
Depreciation of property and equipment	3.9		4.4
Amortization of intangible assets	2.3		2.4
Total operating expenses	102.7		109.2
Operating loss	(2.7	)	(9.2	)
Foreign currency transaction (gains) losses on short-term intercompany balances	5.1		0.1
Interest expense (income), net	(0.1	)	0.1
Loss before income taxes	(7.7	)	(9.4	)
Income tax expense	1.4		0.3
Net loss	(9.1	)%	(9.7	)%

Three Months Ended March 31, 2015 Compared to the Corresponding Period of the Prior Year

Revenue. Revenue was as follows (in thousands):

	Three Months Ended March 31,
	2015		2014
Recovery Audit Services – Americas	$	22,417	$	24,798
Recovery Audit Services – Europe/Asia-Pacific	9,305		9,702
Adjacent Services	1,263		2,283
Healthcare Claims Recovery Audit Services	147		1,118
Total	$	33,132	$	37,901

Total revenue decreased for the three months ended March 31, 2015 by $4.8 million, or 12.6%, compared to the same period in 2014.

Below is a discussion of our revenue for our four reportable segments.

Recovery Audit Services – Americas revenue decreased by $2.4 million, or 9.6%, for the first quarter of 2015 compared to the first quarter of 2014. One of the factors contributing to changes in our reported revenue is the strength of the U.S. dollar relative to foreign currencies. Changes in the average value of the U.S. dollar during the period relative to foreign currencies impacted our reported revenue. On a constant dollar basis, adjusted for changes in foreign exchange (“FX”) rates, revenue for the first quarter of 2015decreased by 6.7% compared to a decrease of 9.6% as reported.

In addition to the impact of the change in FX rates, the year over year net decrease in our Recovery Audit Services – Americas revenue in the three months ended March 31, 2015 was due to a number of factors. Revenue at our existing clients declined 11.9% in the three-month period primarily due to lower contingency fee rates at several clients and a change in position from primary auditor to secondary auditor at a large client. Partially offsetting these declines, revenue increased 2.3% in the three-month period due to new clients.

13

Recovery Audit Services – Europe/Asia-Pacific revenue decreased by $0.4 million, or 4.1%, for the three months ended March 31, 2015 compared to the same period in 2014. The changes in the value of the U.S. dollar relative to foreign currencies in Europe, Asia and the Pacific region negatively impacted reported revenue for the first quarter compared to the same period in 2014. On a constant dollar basis, adjusted for changes in FX rates, revenue increased by 10.0% during the first three months of 2015 compared to a decrease of 4.1% as reported. The 10.0% net increase on a constant dollar basis for the three-month period included net increases in revenue of 8.6% attributable to existing clients, 0.9% attributable to cyclical clients and 0.5% attributable to new clients.

Adjacent Services revenue decreased by $1.0 million, or 44.7%, for the three months ended March 31, 2015 compared to the same period in 2014 primarily due to the sale of our Chicago, Illinois-based consulting practice on October 1, 2014.

Healthcare Claims Recovery Audit Services revenue decreased by $1.0 million, or 86.9%, for the three months ended March 31, 2015 compared to the same period in 2014. The decrease in revenue in the three-month period is primarily due to restrictions imposed on all Medicare RAC program contractors, which negatively impacted our revenue. As disclosed in our Form 10-K for the year ended December 31, 2013, we withdrew from the Medicare RAC program rebid process in February 2014. On April 28, 2015, the Company announced its decision to exit its Healthcare Claims Recovery Audit Services business.

Cost of Revenue (“COR”). COR consists principally of commissions and other forms of variable compensation we pay to our auditors based primarily on the level of overpayment recoveries and/or profit margins derived therefrom, fixed auditor salaries, compensation paid to various types of hourly support staff and salaries for operational and client service managers for our recovery audit services and our Adjacent Services businesses. COR also includes other direct and indirect costs incurred by these personnel, including office rent, travel and entertainment, telephone, utilities, maintenance and supplies and clerical assistance. A significant portion of the components comprising COR is variable and will increase or decrease with increases or decreases in revenue.

COR was as follows (in thousands):

	Three Months Ended March 31,
	2015		2014
Recovery Audit Services – Americas	$	14,971	$	16,000
Recovery Audit Services – Europe/Asia-Pacific	6,437		7,417
Adjacent Services	1,759		3,035
Healthcare Claims Recovery Audit Services	611		2,380
Total	$	23,778	$	28,832

COR as a percentage of revenue for Recovery Audit Services – Americas was 66.8% and 64.5% for the three months ended March 31, 2015 and 2014, respectively. The increase in COR as a percentage of revenue for the three months ended March 31, 2015 compared to the same period in 2014 is primarily due to the fixed portion of our costs not decreasing in line with the lower revenue, and increased compensation expense associated with personnel added to deliver contract compliance services.

COR for Recovery Audit Services – Europe/Asia-Pacific decreased $1.0 million for the three months ended March 31, 2015 compared to the same period in 2014 due primarily to the increase in the value of the U.S. dollar relative to foreign currencies in Europe, Asia and the Pacific region between the 2015 and 2014 periods. On a constant dollar basis, adjusted for changes in foreign currency rates, COR for the first quarter of 2015 did not significantly change compared to the first quarter of 2014.

COR as a percentage of revenue for Recovery Audit Services – Europe/Asia-Pacific is generally higher than COR as a percentage of revenue for Recovery Audit Services – Americas primarily due to differences in service delivery models, scale and geographic fragmentation. The Recovery Audit Services – Europe/Asia-Pacific segment generally serves fewer clients in each geographic market and on average generates lower revenue per client than those served by the Company’s Recovery Audit Services – Americas segment.

COR as a percentage of revenue for Adjacent Services was 139.3% and 132.9% for the three months ended March 31, 2015 and 2014, respectively. COR declined 42.0% in the three months ended March 31, 2015 compared to the same period in 2014 due primarily to the sale of the Chicago, Illinois-based consulting practice on October 1, 2014 as well as reductions in compensation costs for the remaining business as we rationalized and refined our service offerings.

14

Healthcare Claims Recovery Audit Services COR relates primarily to costs associated with the Medicare RAC program subcontracts. COR decreased $1.8 million for the three-month period ended March 31, 2015 compared to the same period in 2014 due primarily to personnel reductions and reduced direct costs associated with the Medicare RAC program such as costs for medical records and other costs associated with the generation of claims. These reductions were not sufficient to enable us to achieve revenue in excess of COR for our services under the Medicare RAC program, resulting in COR exceeding revenue in the 2015 period.

Selling, General and Administrative Expenses (“SG&A”). SG&A expenses for all segments other than Corporate Support include the expenses of sales and marketing activities, information technology services and allocated corporate data center costs, human resources, legal, accounting, administration, foreign currency transaction gains and losses other than those relating to short-term intercompany balances and gains and losses on asset disposals. Corporate Support SG&A represents the unallocated portion of SG&A expenses which are not specifically attributable to our segment activities and include the expenses of information technology services, the corporate data center, human resources, legal, accounting, treasury, administration and stock-based compensation charges.

SG&A expenses were as follows (in thousands):

	Three Months Ended March 31,
	2015		2014
Recovery Audit Services – Americas	$	1,521	$	2,848
Recovery Audit Services – Europe/Asia-Pacific	1,566		1,804
Adjacent Services	200		566
Healthcare Claims Recovery Audit Services	225		624
Subtotal for reportable segments	3,512		5,842
Corporate Support	4,657		4,134
Total	$	8,169	$	9,976

Recovery Audit Services – Americas SG&A decreased by $1.3 million, or 46.6%, for the three months ended March 31, 2015 from the comparable period in 2014 due primarily to lower compensation expense that resulted from our transformation efforts and reductions in bad debt expense.

Recovery Audit Services – Europe/Asia-Pacific SG&A decreased$0.2 million, or 13.2%, for the three months ended March 31, 2015 compared to the same period in 2014. This decrease is primarily due to an increase in the value of the U.S. dollar relative to foreign currencies in Europe, Asia and the Pacific region between the 2015 and 2014 periods. On a constant dollar basis, adjusted for changes in foreign currency rates, SG&A for the first quarter of 2015 decreased by less than $0.1 million compared to the first quarter of 2014.

Adjacent Services SG&A decreased$0.4 million, or 64.7%, in the three months ended March 31, 2015 compared to the same period in 2014. This decrease is primarily due to lower compensation, travel and office-related expenses that declined as a result of personnel reductions that were made as we rationalized our service offerings in this segment.

Healthcare Claims Recovery Audit Services SG&A decreased$0.4 million, or 63.9%, in the three months ended March 31, 2015 compared to the same period in 2014. This decrease is primarily due to reductions in overhead charges and occupancy costs that resulted from staff reductions in this segment necessitated by the decline in Healthcare Claims Recovery Audit Services revenue.

Corporate Support SG&A increased$0.5 million, or 12.7%, for the three months ended March 31, 2015 compared to the same period in 2014. This increase is primarily due to increases in equity compensation expenses and costs associated with our information technology infrastructure initiatives.

15

Depreciation of property and equipment. Depreciation of property and equipment was as follows (in thousands):

	Three Months Ended March 31,
	2015		2014
Recovery Audit Services – Americas	$	969	$	1,256
Recovery Audit Services – Europe/Asia-Pacific	153		146
Adjacent Services	157		160
Healthcare Claims Recovery Audit Services	13		120
Total	$	1,292	$	1,682

The overall decrease in depreciation relates primarily to the mix and timing of our capital expenditures and the associated useful lives for such purchases.

Amortization of intangible assets. Amortization of intangible assets was as follows (in thousands):

	Three Months Ended March 31,
	2015		2014
Recovery Audit Services – Americas	$	441	$	500
Recovery Audit Services – Europe/Asia-Pacific	273		307
Adjacent Services	32		96
Total	$	746	$	903

The decrease in amortization expense for the three months ended March 31, 2015 compared to the same period in 2014 is primarily due to the end of the finite lives of certain intangible assets, no new intangible assets since 2013, and the disposition of intangible assets as a result of the sale of our Chicago, Illinois-based consulting practice on October 1, 2014. We have not recorded any amortization of intangible assets in our Healthcare Claims Recovery Audit Services segment because there have been no business acquisitions in this segment. Unless we complete an acquisition in any of our reportable segments in 2015, we anticipate that amortization expense will continue to decrease in 2015 compared to 2014.

Foreign Currency Transaction (Gains) Losses on Short-Term Intercompany Balances. Foreign currency transaction gains and losses on short-term intercompany balances result from fluctuations in the exchange rates for foreign currencies and the U.S. dollar and the impact of these fluctuations, primarily on balances payable by our foreign subsidiaries to their U.S. parent. Substantial changes from period to period in foreign currency exchange rates may significantly impact the amount of such gains and losses. The strengthening of the U.S. dollar relative to other currencies results in recorded losses on short-term intercompany balances receivable from our foreign subsidiaries while the relative weakening of the U.S. dollar results in recorded gains. In the three months ended March 31, 2015 and 2014, we recorded foreign currency transaction losses of $1.7 million and less than $0.1 million, respectively, on short-term intercompany balances.

Net Interest Expense (Income). Net interest income was less than $0.1 million for the three months ended March 31, 2015 and net interest expense was $0.1 million for the three months ended March 31, 2014. Net interest income in the three months ended March 31, 2015 is primarily due to interest from a time deposit that exceeded total interest expense for the period.

Income Tax Expense. Our income tax expense amounts as reported in the accompanying Condensed Consolidated Financial Statements (Unaudited) do not reflect amounts that normally would be expected due to several factors. The most significant of these factors is that for U.S. tax reporting purposes we have net operating loss carryforwards and other tax attributes which created deferred tax assets on our balance sheet. We reduce our deferred tax assets by a valuation allowance if it is more likely than not that some portion or all of a deferred tax asset will not be realized. Generally, these factors result in our recording no net income tax expense or benefit relating to our operations in the United States. Reported income tax expense for the three months ended March 31, 2015 and 2014 primarily results from taxes on the income of certain of our foreign subsidiaries.

Adjusted EBITDA. We evaluate the performance of our reportable segments based upon revenue and measures of profit or loss we refer to as EBITDA and Adjusted EBITDA. We define Adjusted EBITDA as earnings from continuing operations before interest and taxes (“EBIT”), adjusted for depreciation and amortization (“EBITDA”), and then further adjusted for unusual and other significant items that management views as distorting the operating results of the various segments from period to period. Such adjustments include restructuring charges, stock-based compensation, bargain purchase gains,

16

acquisition-related charges and benefits (acquisition transaction costs, acquisition obligations classified as compensation, and fair value adjustments to acquisition-related contingent consideration), tangible and intangible asset impairment charges, certain litigation costs and litigation settlements, certain severance charges and foreign currency transaction gains and losses on short-term intercompany balances viewed by management as individually or collectively significant.

Reconciliations of net loss to each of EBIT, EBITDA and Adjusted EBITDA for the periods included in this report are as follows (in thousands):

	Three Months Ended March 31,
	2015			2014
Net loss	$	(2,958	)	$	(3,674	)
Income tax expense	455			113
Interest expense (income), net	(42		)	54
EBIT	(2,545		)	(3,507		)
Depreciation of property and equipment	1,292			1,682
Amortization of intangible assets	746			903
EBITDA	(507		)	(922		)
Foreign currency transaction (gains) losses on short-term intercompany balances	1,692			15
Acquisition-related charges	—			19
Transformation severance and related expenses	146			385
Stock-based compensation	1,132			1,021
Adjusted EBITDA	$	2,463		$	518

Transformation severance and related expenses decreased$0.2 million for the three months ended March 31, 2015 compared to the same period in 2014. Transformation severance and related expenses fluctuate with staff reductions and lease expenses associated with vacating office space across all segments in order to reduce our cost structure.

Stock-based compensation increased$0.1 million, or 10.9%, for the three months ended March 31, 2015 compared to the same period in 2014 due to relatively higher expenses associated with equity awards granted during the 2014 fiscal year.

We include a detailed calculation of Adjusted EBITDA by segment in Note D of “Notes to Consolidated Financial Statements” in Item 1 of this Form 10-Q. A summary of Adjusted EBITDA by segment for the three months ended March 31, 2015 and 2014 is as follows (in thousands):

	Three Months Ended March 31,
	2015			2014
Recovery Audit Services – Americas	$	5,981		$	5,958
Recovery Audit Services – Europe/Asia-Pacific	1,367			560
Adjacent Services	(680		)	(1,156		)
Healthcare Claims Recovery Audit Services	(689		)	(1,731		)
Subtotal for reportable segments	5,979			3,631
Corporate Support	(3,516		)	(3,113		)
Total	$	2,463		$	518

Recovery Audit Services – Americas Adjusted EBITDA did not significantly change for the three months ended March 31, 2015 compared to the same period in 2014. The revenue declines experienced by this segment were offset by reductions in COR and SG&A expenses.

Recovery Audit Services – Europe/Asia-Pacific Adjusted EBITDA increased by $0.8 million, or 144.1%, for the three months ended March 31, 2015 compared to the same period in 2014. The increase is due to greater reductions in COR and SG&A expenses than revenue.

17

Adjacent Services Adjusted EBITDA improved $0.5 million for the three months ended March 31, 2015, compared to the same period in 2014. Excluding the impact of the sale of the Chicago-Illinois based consulting practice on October 1, 2014, the improvement in Adjusted EBITDA is primarily due to a decrease in SG&A expenses.

Healthcare Claims Recovery Audit Services Adjusted EBITDA improved $1.0 million, or 60.2%, for the three months ended March 31, 2015 compared to the same period in 2014. This improvement is due to reductions in COR and SG&A expenses that exceeded the reductions in revenue.

Corporate Support Adjusted EBITDA declined by $0.4 million, or 12.9%, for the three months ended March 31, 2015 compared to the same period in 2014. This decrease is due primarily to increased equity compensation and expenses associated with our information technology infrastructure initiatives.

Liquidity and Capital Resources

As of March 31, 2015, we had $23.4 million in cash and cash equivalents and no borrowings outstanding against our $20.0 million revolving credit facility.

Operating Activities. Net cash provided by operating activities was $5.4 million and $2.9 million during the three months ended March 31, 2015 and 2014, respectively. These amounts consist of two components, specifically, net loss adjusted for certain non-cash items (such as depreciation, amortization, stock-based compensation expense, and deferred income taxes) and changes in assets and liabilities, primarily working capital, as follows (in thousands):

	Three Months Ended March 31,
	2015			2014
Net loss	$	(2,958	)	$	(3,674	)
Adjustments for certain non-cash items	5,078			3,428
	2,120			(246		)
Changes in operating assets and liabilities	3,304			3,158
Net cash provided by operating activities	$	5,424		$	2,912

The change in net cash provided by operating activities primarily resulted from changes in operating assets and liabilities as well as the relatively lower net loss compared to the 2014 period. We include an itemization of these changes in our Condensed Consolidated Statements of Cash Flows (Unaudited) in Item 1 of this Form 10-Q.

Investing Activities. Net cash used for property and equipment capital expenditures was $1.1 million and $0.8 million during the three months ended March 31, 2015 and 2014, respectively. These capital expenditures primarily related to investments we made to upgrade our information technology infrastructure.

Capital expenditures are discretionary and we currently expect to continue to make capital expenditures to enhance our information technology infrastructure and proprietary audit tools in 2015. Should we experience changes in our operating results, we may alter our capital expenditure plans.

Financing Activities. Net cash used by financing activities was $5.5 million and net cash provided by financing activities was $0.1 million for the three months ended March 31, 2015 and 2014, respectively. The increase in net cash used by financing activities in the three months ended March 31, 2015 compared to same period in 2014 is primarily due to the $5.5 million of common stock repurchased during the first three months of 2015.

Secured Credit Facility

On January 19, 2010, we entered into a four-year revolving credit and term loan agreement with SunTrust Bank (“SunTrust”). The SunTrust credit facility initially consisted of a $15.0 million committed revolving credit facility and a $15.0 million term loan. The SunTrust term loan required quarterly principal payments of $0.8 million beginning in March 2010, and a final principal payment of $3.0 million due in January 2014 that we paid in December 2013. The SunTrust credit facility is guaranteed by the Company and all of its material domestic subsidiaries and secured by substantially all of the assets of the Company.

On January 17, 2014, we entered into an amendment of the SunTrust credit facility that increased the committed revolving credit facility from $15.0 million to $25.0 million, lowered the applicable margin to a fixed rate of 1.75%, eliminated

18

the provision limiting availability under the revolving credit facility based on eligible accounts receivable, increased our stock repurchase program limits, and extended the scheduled maturity of the revolving credit facility to January 16, 2015 (subject to earlier termination as provided therein).

On December 23, 2014, we entered into an amendment of the SunTrust credit facility that reduced the committed revolving credit facility from $25.0 million to $20.0 million. The credit facility bears interest at a rate per annum comprised of a specified index rate based on one-month LIBOR, plus an applicable margin (1.75% per annum). The credit facility includes two financial covenants (a maximum leverage ratio and a minimum fixed charge coverage ratio) that apply only if we have borrowings under the credit facility that arise or remain outstanding during the final 30 calendar days of any fiscal quarter. These financial covenants also will be tested, on a modified pro forma basis, in connection with each new borrowing under the credit facility. This amendment also extends the scheduled maturity of the revolving credit facility to December 23, 2017 and lowered the commitment fee to 0.25% per annum, payable quarterly, on the unused portion of the revolving credit facility.

As of March 31, 2015, we had no outstanding borrowings under the SunTrust Credit Facility. With the provision of a fixed applicable margin of 1.75% per the amendment of the SunTrust credit facility, the interest rate that would have applied at March 31, 2015 had any borrowings been outstanding was approximately 1.92%.

The SunTrust credit facility includes customary affirmative, negative, and financial covenants binding on the Company, including delivery of financial statements and other reports, maintenance of existence, and transactions with affiliates. The negative covenants limit the ability of the Company, among other things, to incur debt, incur liens, make investments, sell assets or declare or pay dividends on its capital stock. The financial covenants included in the SunTrust credit facility, among other things, limit the amount of capital expenditures the Company can make, set forth maximum leverage and net funded debt ratios for the Company and a minimum fixed charge coverage ratio, and also require the Company to maintain minimum consolidated earnings before interest, taxes, depreciation and amortization. In addition, the SunTrust credit facility includes customary events of default.

We believe that we will have sufficient borrowing capacity and cash generated from operations to fund our capital and operational needs for at least the next twelve months.

Stock Repurchase Program

On February 21, 2014, our Board of Directors authorized a stock repurchase program under which we may repurchase up to $10.0 million of our common stock from time to time through March 31, 2015. On March 25, 2014, our Board of Directors authorized a $10.0 million increase to the stock repurchase program. On October 24, 2014, our Board of Directors authorized a

$20.0 million increase to the stock repurchase program, increasing the total stock repurchase program since its inception to

$40.0 million, and extended the duration of the program to December 31, 2015. From the February 2014 announcement of the Company’s current stock repurchase program through March 31, 2015, the Company has repurchased 4.7 million shares, or 15.7%, of its common stock outstanding on the date of the announcement, for an aggregate cost of $28.2 million. For the three months ended March 31, 2015, we repurchased 1.1 million shares under this plan for and aggregate cost of $5.5 million. These shares were retired and accounted for as a reduction to Shareholders' equity in the Condensed Consolidated Balance Sheet (Unaudited). Direct costs incurred to acquire the shares are included in the total cost of the shares.

The timing and amount of future repurchases, if any, will depend upon the Company’s stock price, the amount of the Company’s available cash, regulatory requirements, and other corporate considerations. The Company may initiate, suspend or discontinue purchases under the stock repurchase program at any time.

Off-Balance Sheet Arrangements

As of March 31, 2015, the Company did not have any material off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of the SEC’s Regulation S-K.

19

Critical Accounting Policies

We describe the Company’s significant accounting policies in Note 1 of Notes to Consolidated Financial Statements of the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. We consider certain of these accounting policies to be “critical” to the portrayal of the Company’s financial position and results of operations, as they require the application of significant judgment by management. As a result, they are subject to an inherent degree of uncertainty. We identify and discuss these “critical” accounting policies in the Management’s Discussion and Analysis of Financial Condition and Results of Operations section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. Management bases its estimates and judgments on historical experience and on various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. On an ongoing basis, management evaluates its estimates and judgments, including those considered “critical”. Management has discussed the development, selection and evaluation of accounting estimates, including those deemed “critical,” and the associated disclosures in this Form 10-Q with the Audit Committee of the Board of Directors.

20

Forward-Looking Statements

Some of the information in this Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which statements involve substantial risks and uncertainties including, without limitation, statements regarding: (1) future results of operations or of the Company’s financial condition, (2) the adequacy of the Company’s current working capital and other available sources of funds, (3) the Company's goals and plans for the future, including its strategic initiatives and growth opportunities, (4) expectations regarding future revenue trends, and (5) the expected impact of the Company’s decision to exit the Company's Healthcare Claims Recovery Audit Services business. All statements that cannot be assessed until the occurrence of a future event or events should be considered forward-looking. These statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and can be identified by the use of forward-looking words such as “may,” “will,” “expect,” “anticipate,” “believe,” “estimate” and “continue” or similar words. Risks and uncertainties that may potentially impact these forward-looking statements include, without limitation, those set forth under Part I, Item 1A “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 and its other periodic reports filed with the Securities and Exchange Commission. The Company disclaims any obligation or duty to update or modify these forward-looking statements.

There may be events in the future, however, that the Company cannot accurately predict or over which the Company has no control. The risks and uncertainties listed in this section, as well as any cautionary language in this Form 10-Q, provide examples of risks, uncertainties and events that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements. You should be aware that the occurrence of any of the events denoted above as risks and uncertainties and elsewhere in this Form 10-Q could have a material adverse effect on our business, financial condition and results of operations.

21

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Foreign Currency Market Risk. Our reporting currency is the U.S. dollar, although we transact business in various foreign locations and currencies. As a result, our financial results could be significantly affected by factors such as changes in foreign currency exchange rates or weak economic conditions in the foreign markets in which we provide our services. Our operating results are exposed to changes in exchange rates between the U.S. dollar and the currencies of the other countries in which we operate. When the U.S. dollar strengthens against other currencies, the value of foreign functional currency revenue decreases. When the U.S. dollar weakens, the value of the foreign functional currency revenue increases. Overall, we are a net receiver of currencies other than the U.S. dollar and, as such, benefit from a weaker dollar. We therefore are adversely affected by a stronger dollar relative to major currencies worldwide. During the three months ended March 31, 2015, we recognized $1.7 million of operating income from operations located outside the U.S., virtually all of which was originally accounted for in currencies other than the U.S. dollar. Upon translation into U.S. dollars, such operating income would increase or decrease, assuming a hypothetical 10% change in weighted-average foreign currency exchange rates against the U.S. dollar, by $0.2 million for the three months ended March 31, 2015. We currently do not have any arrangements in place to hedge our foreign currency risk.

Interest Rate Risk. Our interest income and expense are sensitive to changes in the general level of U.S. interest rates. In this regard, changes in U.S. interest rates affect the interest earned on our cash equivalents as well as interest paid on amounts outstanding under our revolving credit facility, if any. As of March 31, 2015, we had no borrowings outstanding against our $20.0 million revolving credit facility. Interest on our revolving credit facility is payable monthly and accrues at an index rate using the one-month LIBOR rate plus an applicable margin of 1.75%. Assuming full utilization of the revolving credit facility, a hypothetical 100 basis point change in interest rates applicable to the revolver would result in an approximate $0.2 million change in annual pre-tax income.

22

Item 4. Controls and Procedures

The Company carried out an evaluation, under the supervision and with the participation of its management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in the Exchange Act Rule 13a-15(e)) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of March 31, 2015.

There were no changes in the Company’s internal control over financial reporting during the quarter ended March 31, 2015 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

23

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

We are party to a variety of legal proceedings arising in the normal course of business. While the results of these proceedings cannot be predicted with certainty, management believes that the final outcome of these proceedings will not have a material adverse effect on our financial position, results of operations or cash flows.

Item 1A. Risk Factors

There have been no material changes in the risks facing the Company as described in the Company’s Form 10-K for the year ended December 31, 2014.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The Company’s current credit facility prohibits the payment of any cash dividends on the Company’s capital stock.

The following table sets forth information regarding the purchases of the Company’s equity securities made by or on behalf of the Company or any affiliated purchaser (as defined in Exchange Act Rule 10b-18) during the three-month period ended March 31, 2015:

2015	Total Number of Shares Purchased (a)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (b)	Maximum Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
					(millions of dollars)
January 1 - January 31	340,738	$	5.38	331,774	$	—
February 1 - February 28	300,540	$	5.34	300,540	$	—
March 1 - March 31	497,618	$	4.22	497,618	$	—
	1,138,896	$	4.86	1,129,932	11.8

(a) Shares purchased during the quarter include shares surrendered by employees to satisfy tax withholding obligations upon vesting of restricted stock and shares from the Company's stock repurchase program.

(b) On February 21, 2014, our Board of Directors authorized a stock repurchase program under which we may repurchase up to $10.0 million of our common stock from time to time through March 31, 2015. On March 25, 2014, our Board of Directors authorized a $10.0 million increase to the stock repurchase program, bringing the total amount of its common stock that the Company may repurchase under the program to $20.0 million. On October 24, 2014, our Board of Directors authorized a $20.0 million increase to the stock repurchase program, increasing the total share repurchase program to $40.0 million, and extended the duration of the program to December 31, 2015. From the February 2014 announcement through March 31, 2015, the Company repurchased a total of 4,735,074 shares under this program for an aggregate purchase price of $28.2 million. The timing and amount of repurchases, if any, will depend upon the Company’s stock price, economic and market conditions, regulatory requirements, and other corporate considerations. The Company may initiate, suspend or discontinue purchases under the stock repurchase program at any time.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

24

Item 6. Exhibits

Exhibit Number	Description
3.1	Restated Articles of Incorporation of the Registrant, as amended and corrected through August 11, 2006 (restated solely for the purpose of filing with the Commission) (incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed on August 17, 2006).
3.1.1	Articles of Amendment of the Registrant effective January 20, 2010 (incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed on January 25, 2010).
3.2	Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed on December 11, 2007).
4.1	Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 10-K for the year ended December 31, 2001).
4.2	See Restated Articles of Incorporation and Bylaws of the Registrant, filed as Exhibits 3.1 and 3.2, respectively.
10.1	Form of PRGX Performance-Based Restricted Stock Unit Agreement (incorporated by reference to Exhibit 10.1 to the Registrant's Form 8-K filed on April 1, 2015).
31.1	Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a), for the quarter ended March 31, 2015.
31.2	Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a) or 15d-14(a), for the quarter ended March 31, 2015.
32.1	Certification of the Chief Executive Officer and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, for the quarter ended March 31, 2015.
101	The following financial information from the Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2015, formatted in Extensible Business Reporting Language (“XBRL”): (i) Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Statements of Comprehensive Loss, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Cash Flows and (v) Notes to Condensed Consolidated Financial Statements.

25

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	PRGX GLOBAL, INC.
May 8, 2015	By:	/s/ Ronald E. Stewart
		Ronald E. Stewart
		President, Chief Executive Officer, Director (Principal Executive Officer)
May 8, 2015	By:	/s/ Peter Limeri
		Peter Limeri
		Chief Financial Officer and Treasurer (Principal Financial Officer)

26

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Ronald E. Stewart, certify that:

1. I have reviewed this Form 10-Q of PRGX Global, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

(b) Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 8, 2015	By:	/s/ Ronald E. Stewart
		Ronald E. Stewart
		President, Chief Executive Officer, Director (Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Peter Limeri, certify that:

1. I have reviewed this Form 10-Q of PRGX Global, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

(b) Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 8, 2015	By:	/s/ Peter Limeri
		Peter Limeri
		Chief Financial Officer and Treasurer (Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PRGX Global, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ronald E. Stewart, President and Chief Executive Officer of the Company and I, Peter Limeri, Chief Financial Officer and Treasurer, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of the undersigned’s knowledge: (1) the Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 8, 2015	By:	/s/ Ronald E. Stewart
		Ronald E. Stewart
		President, Chief Executive Officer, Director (Principal Executive Officer)
May 8, 2015	By:	/s/ Peter Limeri
		Peter Limeri
		Chief Financial Officer and Treasurer (Principal Financial Officer)

XML

Operating Segments and Related Information (Details Textual)	3 Months Ended
	Mar. 31, 2015 segment
Segment Reporting Information [Line Items]
Number of reportable segments	4

XML

Stock-Based Compensation

3 Months Ended

Mar. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation

Stock-Based Compensation

The Company currently has two stock-based compensation plans under which awards are outstanding: (1) the 2006 Management Incentive Plan (“2006 MIP”) and (2) the 2008 Equity Incentive Plan (“2008 EIP”) (collectively, the “Plans”). We describe the Plans in the Company’s Annual Report on Form 10–K for the fiscal year ended December 31, 2014. For all periods presented herein, awards outside the Plans are referred to as inducement awards.

2008 EIP Awards and Inducement Awards

Stock options granted under the 2008 EIP generally have a term of seven years and vest in equal annual increments over the vesting period, which typically is three years for employees and one year for directors. There were no stock option grants during the three months ended March 31, 2014. The following table summarizes stock option grants during the three months ended March 31, 2015:

Grantee Type	# of Options Granted	Vesting Period	Weighted Average Exercise Price		Weighted Average Grant Date Fair Value
2015
Director	2,849	1 year or less	$	4.07	$	0.97
Director	8,546	3 years	$	4.07	$	1.46
Employee inducements (1)	75,000	3 years	$	5.81	$	1.45

(1) The Company granted non-qualified stock options outside its existing stock-based compensation plans in the first quarter of 2015 to two employees in connection with the employees joining the Company.

Nonvested stock awards, including both restricted stock and restricted stock units, granted under the 2008 EIP generally are nontransferable until vesting and the holders are entitled to receive dividends with respect to the nonvested shares. Prior to vesting, the grantees of restricted stock are entitled to vote the shares, but the grantees of restricted stock units are not entitled to vote the shares. Generally, nonvested stock awards with time-based vesting criteria vest in equal annual increments over the vesting period, which typically is three years for employees and one year for directors. There were no nonvested stock awards (restricted stock and restricted stock units) granted during the three months ended March 31, 2014. The following table summarizes nonvested stock awards granted during the three months ended March 31, 2015:

Grantee Type	# of Shares Granted	Vesting Period	Weighted Average Grant Date Fair Value
2015
Director	2,849	1 year or less	$	4.07
Director	8,546	3 years	$	4.07
Employee group (1)	1,325,000	2 years	$	4.00
Employee inducements (2)	10,000	3 years	$	5.29

(1) The Company granted nonvested performance-based stock awards (restricted stock units) in the first quarter of 2015 to eight executive officers.

(2) The Company granted nonvested stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2015 to two employees in connection with the employees joining the Company.

2006 MIP Performance Units

On June 19, 2012, seven executive officers of the Company were granted 154,264 Performance Units under the 2006 MIP, comprising all of the then remaining available awards under the 2006 MIP. The awards had an aggregate grant date fair value of $1.2 million and vest ratably over three years. Upon vesting, the Performance Units will be settled by the issuance of Company common stock equal to 60% of the number of Performance Units being settled and the payment of cash in an amount equal to 40% of the fair market value of that number of shares of common stock equal to the number of Performance Units being settled. During the three months endedMarch 31, 2015, an aggregate of 6,200 Performance Units were settled, which resulted in the issuance of 3,720 shares of common stock and cash payments of less than $0.1 million. There were no Performance Units settled during the three months endedMarch 31, 2014. Since the June 19, 2012 grant date to March 31, 2015, an aggregate of 127,410 Performance Units were settled by two current executive officers and four former executive officers, and 16,524 Performance Units were forfeited by one former executive officer and currently are available to be granted. Such settlements resulted in the issuance of 73,158 shares of common stock and cash payments totaling $0.3 million. As of March 31, 2015, a total of 10,330 Performance Units were outstanding, none of which were vested.

Performance-Based Restricted Stock Units

On March 30, 2015, eight executive officers of the Company were granted 1,325,000 performance-based restricted stock units (“PBUs”) under the 2008 EIP. Upon vesting, the PBUs will be settled by the issuance of Company common stock equal to 50% of the number of PBUs being settled and the payment of cash in an amount equal to 50% of the fair market value of that number of shares of common stock equal to the number of PBUs being settled. The PBUs vest and become payable based on the cumulative adjusted EBITDA that the Company (excluding the Healthcare Claims Recovery Audit business) achieves for the two-year performance period ending December 31, 2016. At the threshold performance level, 35% of the PBUs will become vested and payable; at the target performance level, 100% of the PBUs will become vested and payable; and at the maximum performance level, 200% of the PBUs will become vested and payable. If performance falls between the stated performance levels, the percentage of PBUs that shall become vested and payable will be based on straight line interpolation between such stated performance levels (although the PBUs may not become vested and payable for more than 200% of the PBUs and no PBUs shall become vested and payable if performance does not equal or exceed the threshold performance level).

Selling, general and administrative expenses for the three months ended March 31, 2015 and 2014 include $1.1 million and $1.0 million, respectively, related to stock-based compensation charges. At March 31, 2015, there was $14.9 million of unrecognized stock-based compensation expense related to stock options, restricted stock awards, restricted stock unit awards, and Performance Unit awards which we expect to recognize over a weighted-average period of 1.8 years. The unrecognized stock-based compensation expense related to restricted stock unit awards with performance vesting criteria is based on our estimate of both the number of shares of the Company's common stock that will ultimately be issued and cash payments that will be made when the restricted stock units are settled.

XML

Fair Value of Financial Instruments (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Bank Loan Obligations [Member]
Fair Value of Financial Instruments (Textual) [Abstract]
Fair value of long term debt	$ 0	$ 0
Business Acquisition Obligations [Member]
Fair Value of Financial Instruments (Textual) [Abstract]
Fair value of long term debt	$ 0	$ 0

XML

Debt (Details Textual) (USD $)	3 Months Ended	0 Months Ended	3 Months Ended
	Mar. 31, 2015	Jan. 19, 2010	Mar. 31, 2014	Dec. 31, 2014
SunTrust Bank [Member]
Line of Credit Facility [Line Items]
Four-year revolving credit & Term Loan agreement	Jan. 19, 2010
Period of term loan and the revolving credit facility	4 years
Index rate used as reference for interest rate on revolver and term loan	One-month LIBOR rate
Sun Trust Term Loan [Member]
Line of Credit Facility [Line Items]
Period of term loan and the revolving credit facility		4 years
Sun Trust Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Revolving credit facility outstanding	0
Debt Instrument, Frequency of Periodic Payment	Quarterly		Quarterly
Sun Trust Revolving Credit Facility [Member] | SunTrust Bank [Member]
Line of Credit Facility [Line Items]
Committed revolving credit facility	20,000,000			20,000,000
Line of Credit Facility, Fair Value of Amount Outstanding	0
Applicable margin (percent)	1.75%
Debt Instrument, Interest Rate During Period	1.92%
Revolving Credit facility commitment fee (percent)	0.25%

XML

Earnings Per Common Share

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Earnings (Loss) Per Common Share

Earnings (Loss) Per Common Share

The following tables set forth the computations of basic and diluted earnings (loss) per common share for the three months ended March 31, 2015 and 2014 (in thousands, except per share data):

	Three Months Ended March 31,
Basic earnings (loss) per common share:	2015			2014
Numerator:
Net loss	$	(2,958	)	$	(3,674	)
Denominator:
Weighted-average common shares outstanding	26,394			30,159
Basic earnings (loss) per common share	$	(0.11	)	$	(0.12	)

	Three Months Ended March 31,
Diluted earnings (loss) per common share:	2015			2014
Numerator:
Net loss	$	(2,958	)	$	(3,674	)
Denominator:
Weighted-average common shares outstanding	26,394			30,159
Incremental shares from stock-based compensation plans	—			—
Denominator for diluted earnings (loss) per common share	26,394			30,159
Diluted earnings (loss) per common share	$	(0.11	)	$	(0.12	)

For the three months ended March 31, 2015, weighted-average common shares outstanding excludes from the computation of diluted earnings (loss) per common share antidilutive shares underlying options that totaled 3.3 million shares and antidilutive Performance Units issuable under the Company's 2006 Management Incentive Plan that totaled less than 0.1 million shares. For the three months ended March 31, 2014, weighted-average common shares outstanding excludes from the computation of diluted earnings (loss) per common share antidilutive shares underlying options that totaled 2.4 million shares and antidilutive Performance Units related to the Company's 2006 Management Incentive Plan that totaled less than 0.1 million shares. As a result of the net loss for the three months ended March 31, 2015 and March 31, 2014, all shares underlying stock options and Performance Units were considered antidilutive. The number of common shares we used in the basic and diluted earnings (loss) per common share computations include nonvested restricted shares of 0.5 million and 0.7 million for the three months ended March 31, 2015 and 2014, respectively, and nonvested restricted share units that we consider to be participating securities of 1.4 million and 0.2 million for the three months ended March 31, 2015 and 2014, respectively.

We repurchased 1,129,932 shares of our common stock during the three months ended March 31, 2015 for $5.5 million, and 6,700 shares of our common stock during the three months ended March 31, 2014 for less than $0.1 million.

Pursuant to exercises of outstanding stock options, we issued 12,863 shares of our common stock having a value of less than $0.1 million in the three months ended March 31, 2015 and 563,514 shares of our common stock having a value of $2.2 million in the three months ended March 31, 2014. Stock option exercises during the three-month period ended March 31, 2014 primarily consisted of exercises by a former executive officer of the Company.

In partial satisfaction of a business acquisition obligation, we issued 187,620 shares of our common stock having a value of $1.3 million in the three months ended March 31, 2014. There were no shares issued to satisfy business acquisition obligations in the three months ended March 31, 2015.

XML

Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Revenue	$ 33,132	$ 37,901
Operating expenses:
Cost of revenue	23,778	28,832
Selling, general and administrative expenses	8,169	9,976
Depreciation of property and equipment	1,292	1,682
Amortization of intangible assets	746	903
Total operating expenses	33,985	41,393
Operating loss	(853)	(3,492)
Foreign currency transaction (gains) losses on short-term intercompany balances	1,692	15
Interest expense (income), net	(42)	54
Loss before income taxes	(2,503)	(3,561)
Income tax expense	455	113
Net loss	$ (2,958)	$ (3,674)
Basic earnings (loss) per common share (Note B) (usd per share)	$ (0.11)	$ (0.12)
Diluted earnings (loss) per common share (Note B) (usd per share)	$ (0.11)	$ (0.12)
Weighted-average common shares outstanding (Note B):
Basic (shares)	26,394	30,159
Diluted (shares)	26,394	30,159

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net loss	$ (2,958)	$ (3,674)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,038	2,585
Amortization of deferred loan costs	0	16
Stock-based compensation expense	1,132	1,021
Deferred income taxes	216	(209)
Foreign currency transaction (gains) losses on short-term intercompany balances	1,692	15
Changes in operating assets and liabilities:
Restricted cash	(54)	(69)
Billed receivables	3,688	3,055
Unbilled receivables	2,396	4,177
Prepaid expenses and other current assets	647	706
Other assets	27	1
Accounts payable and accrued expenses	(963)	(3,192)
Accrued payroll and related expenses	(2,148)	(1,453)
Refund liabilities	(492)	(647)
Deferred revenue	170	309
Noncurrent compensation obligations	0	184
Other long-term liabilities	33	87
Net cash provided by operating activities	5,424	2,912
Cash flows from investing activities:
Purchases of property and equipment, net of disposal proceeds	(1,116)	(844)
Net cash used in investing activities	(1,116)	(844)
Cash flows from financing activities:
Payment of deferred loan costs	0	(80)
Restricted stock remitted by employees for taxes	(51)	(5)
Proceeds from option exercises	45	2,183
Payments of deferred acquisition consideration	0	(1,978)
Repurchase of common stock	(5,488)	(40)
Net cash (used in) provided by financing activities	(5,494)	80
Effect of exchange rates on cash and cash equivalents	(1,161)	(151)
Net increase (decrease) in cash and cash equivalents	(2,347)	1,997
Cash and cash equivalents at beginning of period	25,735	43,700
Cash and cash equivalents at end of period	23,388	45,697
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	14	19
Cash paid during the period for income taxes, net of refunds received	$ 188	$ 948

XML

Earnings Per Common Share (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]
Number of common shares in the basic and diluted earnings per common share (shares)	500,000	700,000
Nonvested restricted share (shares)	1,400,000	200,000
Stock Repurchased and Retired During Period, Shares	1,129,932	6,700
Stock Repurchased and Retired During Period, Value	$ 5,500,000	$ 100,000
Stock Issued During Period, Shares, Other	12,863	563,514
Stock Issued During Period, Value, Stock Options Exercised	100,000	2,183,000
Business Strategy, Inc. [Member]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]
Business combination, consideration paid in common stock, shares	0	187,620
Business combination, consideration paid in common stock, value		$ 1,300,000
Non-qualified Option [Member]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]
Weighted average shares outstanding excludes anti-dilutive shares underlying options (shares) (less than)	3,300,000	2,400,000
Performance Unit [Member]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]
Weighted average shares outstanding excludes anti-dilutive shares underlying options (shares) (less than)	100,000	100,000

XML

Stock-Based Compensation (Details Textual) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended			0 Months Ended		1 Months Ended	33 Months Ended
	Mar. 31, 2015 compensation_plan		Mar. 31, 2014	Mar. 30, 2015	Jun. 19, 2012	Jun. 30, 2012	Mar. 31, 2015
Stock-Based Compensation (Textual) [Abstract]
Number of stock-based compensation plans	2
Selling, general and administrative expenses	$ 1.1		$ 1.0
Unrecognized stock-based compensation expense related to stock options	14.9						14.9
Weighted-average period for recognizing stock compensation expense	1 year 9 months 0 days
2008 Equity Incentive Plan [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options expiration period	7 years
Employee Group [Member] | 2008 Equity Incentive Plan [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options vesting period	3 years		3 years
Director [Member] | 2008 Equity Incentive Plan [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options vesting period	1 year
Performance Shares [Member] | 2008 Equity Incentive Plan [Member]
Stock-Based Compensation (Textual) [Abstract]
Total of performance units were outstanding (shares)				1,325,000
Number of executive officers granted stock awards				8
Percentage of performance units in equity (percent)				50.00%
Percentage of performance units in cash (percent)				50.00%
Performance period				2 years
Performance Shares [Member] | 2008 Equity Incentive Plan [Member] | Threshold performance level [Member]
Stock-Based Compensation (Textual) [Abstract]
Performance level percentage				35.00%
Performance Shares [Member] | 2008 Equity Incentive Plan [Member] | Target performance level [Member]
Stock-Based Compensation (Textual) [Abstract]
Performance level percentage				100.00%
Performance Shares [Member] | 2008 Equity Incentive Plan [Member] | Maximum performance level [Member]
Stock-Based Compensation (Textual) [Abstract]
Performance level percentage				200.00%
Performance Shares [Member] | 2006 Management Incentive Plan [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options vesting period	3 years
Total of performance units were outstanding (shares)	10,330				154,264		10,330
Number of executive officers granted stock awards					7
Grant date fair value awards						1.2
Percentage of performance units in equity (percent)					60.00%
Percentage of performance units in cash (percent)					40.00%
Performance units settled in period (shares)	6,200		0				127,410
Number of executive officers that settled performance units in period (executive officers)	2
Number of former executive officers that settled performance units in period (executive officers)	4
Performance units forfeited in period (shares)	16,524
Number of former executive officers that forfeited performance units in period (executive officer)	1
Common stock issued during period (shares)	3,720						73,158
Cash payments for shares settled during period	$ 0.1						$ 0.3
Restricted Stock and Restricted Stock Units [Member] | 2008 Equity Incentive Plan [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options award vesting right	vest in equal annual increments over the vesting period
Restricted Stock and Restricted Stock Units [Member] | Employee Group [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options vesting period	3 years
Restricted Stock and Restricted Stock Units [Member] | Employee Group [Member] | 2008 Equity Incentive Plan [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options vesting period	2 years	[1]	2 years
Restricted Stock and Restricted Stock Units [Member] | Director group 1 [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options vesting period	1 year
Restricted Stock and Restricted Stock Units [Member] | Director [Member] | 2008 Equity Incentive Plan [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options vesting period	1 year
Stock Options [Member] | 2008 Equity Incentive Plan [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options expiration period	7 years
Stock options award vesting right	vest in equal annual increments over the vesting period
Stock Options [Member] | Employee Group [Member] | 2008 Equity Incentive Plan [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options vesting period	3 years
Stock Options [Member] | Director [Member] | 2008 Equity Incentive Plan [Member]
Stock-Based Compensation (Textual) [Abstract]
Stock options vesting period	1 year

[1] (1)The Company granted nonvested performance-based stock awards (restricted stock units) in the first quarter of 2015 to eight executive officers.

XML

Basis of Presentation

3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying Condensed Consolidated Financial Statements (Unaudited) of PRGX Global, Inc. and its wholly owned subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three-month period ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015.

Except as otherwise indicated or unless the context otherwise requires, “PRGX,” “we,” “us,” “our” and the “Company” refer to PRGX Global, Inc. and its subsidiaries. For further information, refer to the Consolidated Financial Statements and Footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2014.

Beginning with the second quarter of 2014, we reclassified certain information technology expenses within our Recovery Audit Services — Americas segment from Selling, General and Administrative expenses to Cost of Revenue to better reflect the nature of the work performed. We have revised the presentation of our Selling, General and Administrative expenses and Cost of Revenue for all relevant prior periods.

New Accounting Standards

A summary of the new accounting standards issued by the Financial Accounting Standards Board (“FASB”) and included in the Accounting Standards Codification (“ASC”) that apply to PRGX is set forth below:

FASB ASC Update No. 2015-03. In April 2015, the FASB issued Accounting Standards Update No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30) (“ASU 2015-03”). ASU 2015-03 simplifies presentation of debt issuance costs by requiring that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for annual periods beginning after December 15, 2015 with early adoption permitted. The guidance also requires retrospective application to all prior periods presented. We are currently evaluating of the impact of ASU 2015-03 on our consolidated financial statements.

FASB ASC Update No. 2014-15. In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40) (“ASU 2014-15”). ASU 2014-15 provides guidance on management's responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and related disclosure requirements. ASU 2014-15 is effective for annual periods beginning after December 15, 2016 with early adoption permitted. We do not expect the adoption of ASU 2014-15 to have a material impact on our consolidated financial statements.

FASB ASC Update No. 2014-09. In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in Revenue Recognition (Topic 605), and requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the transferring entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 allows for adoption using either of two methods; retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of application recognized at the date of initial adoption. It is effective for annual periods beginning after December 15, 2016. Early adoption is not permitted. We are currently evaluating the impact of ASU 2014-09 on our consolidated financial statements.

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net loss	$ (2,958)	$ (3,674)
Foreign currency translation adjustments	(31)	(70)
Comprehensive loss	$ (2,989)	$ (3,744)

XML

Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

New Accounting Standards

New Accounting Standards

A summary of the new accounting standards issued by the Financial Accounting Standards Board (“FASB”) and included in the Accounting Standards Codification (“ASC”) that apply to PRGX is set forth below:

FASB ASC Update No. 2015-03. In April 2015, the FASB issued Accounting Standards Update No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30) (“ASU 2015-03”). ASU 2015-03 simplifies presentation of debt issuance costs by requiring that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for annual periods beginning after December 15, 2015 with early adoption permitted. The guidance also requires retrospective application to all prior periods presented. We are currently evaluating of the impact of ASU 2015-03 on our consolidated financial statements.

FASB ASC Update No. 2014-15. In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40) (“ASU 2014-15”). ASU 2014-15 provides guidance on management's responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and related disclosure requirements. ASU 2014-15 is effective for annual periods beginning after December 15, 2016 with early adoption permitted. We do not expect the adoption of ASU 2014-15 to have a material impact on our consolidated financial statements.

FASB ASC Update No. 2014-09. In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in Revenue Recognition (Topic 605), and requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the transferring entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 allows for adoption using either of two methods; retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of application recognized at the date of initial adoption. It is effective for annual periods beginning after December 15, 2016. Early adoption is not permitted. We are currently evaluating the impact of ASU 2014-09 on our consolidated financial statements.

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	Apr. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	PRGX GLOBAL, INC.
Entity Central Index Key	0001007330
Document Type	10-Q
Document Period End Date	Mar. 31, 2015
Amendment Flag	false
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		25,659,719

XML

Earnings Per Common Share (Tables)

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Computations of basic and diluted earnings (loss) per common share

The following tables set forth the computations of basic and diluted earnings (loss) per common share for the three months ended March 31, 2015 and 2014 (in thousands, except per share data):

	Three Months Ended March 31,
Basic earnings (loss) per common share:	2015			2014
Numerator:
Net loss	$	(2,958	)	$	(3,674	)
Denominator:
Weighted-average common shares outstanding	26,394			30,159
Basic earnings (loss) per common share	$	(0.11	)	$	(0.12	)

	Three Months Ended March 31,
Diluted earnings (loss) per common share:	2015			2014
Numerator:
Net loss	$	(2,958	)	$	(3,674	)
Denominator:
Weighted-average common shares outstanding	26,394			30,159
Incremental shares from stock-based compensation plans	—			—
Denominator for diluted earnings (loss) per common share	26,394			30,159
Diluted earnings (loss) per common share	$	(0.11	)	$	(0.12	)

XML

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents (Note E)	$ 23,388	$ 25,735
Restricted cash	107	53
Contract receivables, less allowances of $2,077 in 2015 and $2,243 in 2014:
Billed	27,646	32,373
Unbilled	1,027	2,809
Receivables Net	28,673	35,182
Employee advances and miscellaneous receivables, less allowances of $626 in 2015 and $692 in 2014	1,854	1,993
Total receivables	30,527	37,175
Prepaid expenses and other current assets	2,842	3,421
Total current assets	56,864	66,384
Property and equipment	56,477	56,174
Less accumulated depreciation and amortization	(44,632)	(43,954)
Property and equipment, net	11,845	12,220
Goodwill	12,994	13,036
Intangible assets, less accumulated amortization of $34,306 in 2015 and $33,973 in 2014	8,651	9,439
Noncurrent portion of unbilled receivables	582	1,196
Other assets	500	507
Total assets	91,436	102,782
Current liabilities:
Accounts payable and accrued expenses	6,185	7,397
Accrued payroll and related expenses	12,782	15,415
Refund liabilities	5,009	5,393
Deferred revenue	2,301	2,173
Other Liabilities, Current	239	0
Total current liabilities	26,516	30,378
Noncurrent refund liabilities	749	857
Other long-term liabilities	568	561
Total liabilities	27,833	31,796
Commitments and contingencies (Note H)
Shareholders’ equity (Note B):
Common stock, no par value; $.01 stated value per share. Authorized 50,000,000 shares; 25,654,992 shares issued and outstanding at March 31, 2015 and 26,762,861 shares issued and outstanding at December 31, 2014	257	268
Additional paid-in capital	585,684	590,067
Accumulated deficit	(523,870)	(520,912)
Accumulated other comprehensive income	1,532	1,563
Total shareholders’ equity	63,603	70,986
Total liabilities and shareholders' equity	$ 91,436	$ 102,782

XML

Debt

3 Months Ended

Mar. 31, 2015

Debt Disclosure [Abstract]

Debt

Debt

On January 19, 2010, we entered into a four-year revolving credit and term loan agreement (the “2010 Credit Agreement”) with SunTrust Bank (“SunTrust”). Subsequent modifications of the 2010 Credit Agreement were entered into with SunTrust. Most recently, on December 23, 2014, we entered into an amended and restated revolving credit agreement (the “Credit Facility”) with SunTrust. The Credit Facility, and provisions of the 2010 Credit Agreement where applicable, is guaranteed by the Company and all of its material domestic subsidiaries and secured by substantially all of the assets of the Company.

The amount available for borrowing under the Credit Facility is $20.0 million, and as of March 31, 2015 we had no outstanding borrowings. With the Credit Facility provision of a fixed applicable margin of 1.75% plus a specified index rate based on one-month LIBOR, the interest rate that would have applied at March 31, 2015 had any borrowings been outstanding was approximately 1.92%. We also must pay a commitment fee of 0.25% per annum, payable quarterly, on the unused portion of the Credit Facility.

The Credit Facility includes customary affirmative, negative, and financial covenants binding on the Company, including delivery of financial statements and other reports, maintenance of existence, and transactions with affiliates. The negative covenants limit the ability of the Company, among other things, to incur debt, incur liens, make investments, sell assets or declare or pay dividends on its capital stock. The financial covenants included in the Credit Facility, among other things, limit the amount of capital expenditures the Company can make, set forth maximum leverage and net funded debt ratios for the Company and a minimum fixed charge coverage ratio, and also require the Company to maintain minimum consolidated earnings before interest, taxes, depreciation and amortization. In addition, the Credit Facility includes customary events of default. The Company was in compliance with the covenants in its Credit Facility as of March 31, 2015.

XML

Cash and Cash Equivalents

3 Months Ended

Mar. 31, 2015

Cash and Cash Equivalents [Abstract]

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents include all cash balances and highly liquid investments with an initial maturity of three months or less from date of purchase. We place our temporary cash investments with high credit quality financial institutions. At times, certain investments may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limit or otherwise may not be covered by FDIC insurance. Some of our cash and cash equivalents are held at banks in jurisdictions outside the U.S. that have restrictions on transferring such assets outside of these countries on a temporary or permanent basis. Such restricted net assets are not significant in comparison to our consolidated net assets.

Our cash and cash equivalents included short-term investments of approximately $6.6 million as of March 31, 2015 and $12.2 million as of December 31, 2014, of which approximately $2.9 million and $2.5 million, respectively, were held at banks outside of the United States, primarily in Brazil and Canada.

XML

Stock-Based Compensation (Details) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
2008 Equity Incentive Plan [Member] | Director [Member]
Summary of nonvested stock awards granted
Vesting Period	1 year
2008 Equity Incentive Plan [Member] | Director group 1 [Member]
Summary of nonvested stock awards granted
Grantee Type, options	Director		Director group
No. of Options Granted (shares)	2,849		0
Vesting Period	1 year or less		1 year or less
Weighted Average Exercise Price	$ 4.07		$ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 0.97		$ 0.00
2008 Equity Incentive Plan [Member] | Director group 2 [Member]
Summary of nonvested stock awards granted
Grantee Type, options	Director		Director group
No. of Options Granted (shares)	8,546		0
Vesting Period	3 years		3 years
Weighted Average Exercise Price	$ 4.07		$ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 1.46		$ 0.00
2008 Equity Incentive Plan [Member] | Employees [Member]
Summary of nonvested stock awards granted
Grantee Type, options			Employee group
No. of Options Granted (shares)			0
Vesting Period	3 years		3 years
Weighted Average Exercise Price			$ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 0.00
Restricted Stock and Restricted Stock Units [Member] | Director group 1 [Member]
Summary of nonvested stock awards granted
Vesting Period	1 year
Restricted Stock and Restricted Stock Units [Member] | Employees [Member]
Summary of nonvested stock awards granted
Vesting Period	3 years
Restricted Stock and Restricted Stock Units [Member] | 2008 Equity Incentive Plan [Member] | Director [Member]
Summary of nonvested stock awards granted
Vesting Period	1 year
Restricted Stock and Restricted Stock Units [Member] | 2008 Equity Incentive Plan [Member] | Director group 1 [Member]
Summary of nonvested stock awards granted
Grantee Type, nonvested stock awards	Director		Director group
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	2,849		0
Vesting Period	1 year or less		1 year or less
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 4.07		$ 0.00
Restricted Stock and Restricted Stock Units [Member] | 2008 Equity Incentive Plan [Member] | Director group 2 [Member]
Summary of nonvested stock awards granted
Grantee Type, nonvested stock awards	Director		Director group
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	8,546		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 4.07		$ 0.00
Vesting Period	3 years		3 years
Restricted Stock and Restricted Stock Units [Member] | 2008 Equity Incentive Plan [Member] | Employees [Member]
Summary of nonvested stock awards granted
Grantee Type, nonvested stock awards	Employee group (1)	[1]	Employee group
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	1,325,000	[1]	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 4.00	[1]	$ 0.00
Vesting Period	2 years	[1]	2 years
Restricted Stock and Restricted Stock Units [Member] | Inducement Award [Member] | Employee inducements [Member]
Summary of nonvested stock awards granted
Grantee Type, nonvested stock awards	Employee inducements (2)	[2]	Employee inducement
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	10,000	[2]	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 5.29	[2]	$ 0.00
Vesting Period	3 years	[2]	3 years
Employee Stock Option [Member] | 2008 Equity Incentive Plan [Member] | Director [Member]
Summary of nonvested stock awards granted
Vesting Period	1 year
Employee Stock Option [Member] | 2008 Equity Incentive Plan [Member] | Employees [Member]
Summary of nonvested stock awards granted
Vesting Period	3 years
Employee Stock Option [Member] | Inducement Award [Member] | Employee inducements [Member]
Summary of nonvested stock awards granted
Grantee Type, nonvested stock awards	Employee inducements (1)	[3]	Employee inducement
No. of Options Granted (shares)	75,000	[3]	0
Vesting Period	3 years	[3]	3 years
Weighted Average Exercise Price	$ 5.81	[3]	$ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 1.45	[3]	$ 0.00

[1] (1)The Company granted nonvested performance-based stock awards (restricted stock units) in the first quarter of 2015 to eight executive officers.

[2] (2)The Company granted nonvested stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2015 to two employees in connection with the employees joining the Company.

[3] (1)The Company granted non-qualified stock options outside its existing stock-based compensation plans in the first quarter of 2015 to two employees in connection with the employees joining the Company.

XML

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary of stock option grants

The following table summarizes stock option grants during the three months ended March 31, 2015:

Grantee Type	# of Options Granted	Vesting Period	Weighted Average Exercise Price		Weighted Average Grant Date Fair Value
2015
Director	2,849	1 year or less	$	4.07	$	0.97
Director	8,546	3 years	$	4.07	$	1.46
Employee inducements (1)	75,000	3 years	$	5.81	$	1.45

(1) The Company granted non-qualified stock options outside its existing stock-based compensation plans in the first quarter of 2015 to two employees in connection with the employees joining the Company.

Summary of nonvested stock awards granted

The following table summarizes nonvested stock awards granted during the three months ended March 31, 2015:

Grantee Type	# of Shares Granted	Vesting Period	Weighted Average Grant Date Fair Value
2015
Director	2,849	1 year or less	$	4.07
Director	8,546	3 years	$	4.07
Employee group (1)	1,325,000	2 years	$	4.00
Employee inducements (2)	10,000	3 years	$	5.29

(1) The Company granted nonvested performance-based stock awards (restricted stock units) in the first quarter of 2015 to eight executive officers.

(2) The Company granted nonvested stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2015 to two employees in connection with the employees joining the Company.

XML

Income Taxes

3 Months Ended

Mar. 31, 2015

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Reported income tax expense in each period primarily results from taxes on the income of foreign subsidiaries. The effective tax rates generally differ from the expected tax rate due primarily to the Company’s deferred tax asset valuation allowance on the domestic earnings and taxes on income of foreign subsidiaries.

Significant judgment is required in evaluating our uncertain tax positions and determining our provision for income taxes. In addition, we are subject to the continuous examination of our income tax returns by the Internal Revenue Service in the U.S. and other tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes.

We apply a “more-likely-than-not” recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. We refer to GAAP for guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. In accordance with FASB ASC 740, our policy for recording interest and penalties associated with tax positions is to record such items as a component of income before income taxes. A number of years may elapse before a particular tax position is audited and finally resolved or when a tax assessment is raised. The number of years subject to tax assessments also varies by tax jurisdiction.

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2015

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

We state cash equivalents at cost, which approximates fair market value. The carrying values for receivables from clients, unbilled services, accounts payable, deferred revenue and other accrued liabilities reasonably approximate fair market value due to the nature of the financial instrument and the short term maturity of these items.

We had no debt outstanding as of March 31, 2015 and December 31, 2014. We consider the factors used in determining the fair value of debt to be Level 3 inputs (significant unobservable inputs).

We had no business acquisition obligations as of March 31, 2015 and December 31, 2014. We determine the estimated fair values of business acquisition obligations based on our projections of future revenue and profits or other factors used in the calculation of the ultimate payment to be made. The discount rate that we use to value the liability is based on specific business risk, cost of capital, and other factors. We consider these factors to be Level 3 inputs (significant unobservable inputs).

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Legal Proceedings

We are party to a variety of legal proceedings arising in the normal course of business. While the results of these proceedings cannot be predicted with certainty, management believes that the final outcome of these proceedings will not have a material adverse effect on our financial position, results of operations or cash flows.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2015

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

On April 28, 2015, the Company announced its decision to exit its Healthcare Claims Recovery Audit Services business due to the continued challenges in the Medicare RAC business and our lack of a diversified client base in that segment.

XML

Earnings Per Common Share (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Numerator:
Net loss	$ (2,958)	$ (3,674)
Denominator:
Weighted-average common shares outstanding (shares)	26,394	30,159
Basic earnings (loss) per common share (usd per share)	$ (0.11)	$ (0.12)
Numerator:
Net loss	$ (2,958)	$ (3,674)
Denominator:
Weighted-average common shares outstanding (shares)	26,394	30,159
Incremental shares from stock-based compensation plans (shares)	0	0
Denominator for diluted earnings (loss) per common share (shares)	26,394	30,159
Diluted earnings (loss) per common share (usd per share)	$ (0.11)	$ (0.12)

XML

Operating Segments and Related Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Segment information
Revenue	$ 33,132	$ 37,901
Net loss	(2,958)	(3,674)
Income tax expense	455	113
Interest expense (income), net	(42)	54
EBIT	(2,545)	(3,507)
Depreciation of property and equipment	1,292	1,682
Amortization of intangible assets	746	903
EBITDA	(507)	(922)
Foreign currency transaction (gains) losses on short-term intercompany balances	1,692	15
Acquisition-related charges (benefits)		19
Transformation severance and related expenses	146	385
Stock-based compensation	1,132	1,021
Adjusted EBITDA	2,463	518
Recovery Audit Services - Americas [Member]
Segment information
Revenue	22,417	24,798
EBIT	4,078	4,084
Depreciation of property and equipment	969	1,256
Amortization of intangible assets	441	500
EBITDA	5,488	5,840
Foreign currency transaction (gains) losses on short-term intercompany balances	437	110
Acquisition-related charges (benefits)		0
Transformation severance and related expenses	56	8
Stock-based compensation	0	0
Adjusted EBITDA	5,981	5,958
Recovery Audit Services - Europe/Asia-Pacific [Member]
Segment information
Revenue	9,305	9,702
EBIT	(442)	101
Depreciation of property and equipment	153	146
Amortization of intangible assets	273	307
EBITDA	(16)	554
Foreign currency transaction (gains) losses on short-term intercompany balances	1,318	(73)
Acquisition-related charges (benefits)		0
Transformation severance and related expenses	65	79
Stock-based compensation	0	0
Adjusted EBITDA	1,367	560
Adjacent Services [Member]
Segment information
Revenue	1,263	2,283
EBIT	(885)	(1,574)
Depreciation of property and equipment	157	160
Amortization of intangible assets	32	96
EBITDA	(696)	(1,318)
Foreign currency transaction (gains) losses on short-term intercompany balances	0	0
Acquisition-related charges (benefits)		19
Transformation severance and related expenses	16	143
Stock-based compensation	0	0
Adjusted EBITDA	(680)	(1,156)
Healthcare Claims Recovery Audit Services [Member]
Segment information
Revenue	147	1,118
EBIT	(702)	(2,006)
Depreciation of property and equipment	13	120
Amortization of intangible assets	0	0
EBITDA	(689)	(1,886)
Foreign currency transaction (gains) losses on short-term intercompany balances	0	0
Acquisition-related charges (benefits)		0
Transformation severance and related expenses	0	155
Stock-based compensation	0	0
Adjusted EBITDA	(689)	(1,731)
Corporate Support [Member]
Segment information
EBIT	(4,594)	(4,112)
Depreciation of property and equipment	0	0
Amortization of intangible assets	0	0
EBITDA	(4,594)	(4,112)
Foreign currency transaction (gains) losses on short-term intercompany balances	(63)	(22)
Acquisition-related charges (benefits)		0
Transformation severance and related expenses	9	0
Stock-based compensation	1,132	1,021
Adjusted EBITDA	$ (3,516)	$ (3,113)

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Allowances for contract receivables	$ 2,077	$ 2,243
Allowances for employee advances and miscellaneous receivables	626	692
Accumulated amortization on intangible assets	$ 34,306	$ 33,973
Common stock, par value (usd per share)	$ 0	$ 0
Common stock, stated value per share (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized (shares)	50,000,000	50,000,000
Common stock, shares issued (shares)	25,654,992	26,762,861
Common stock, shares outstanding (shares)	25,654,992	26,762,861

XML

Operating Segments and Related Information

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Operating Segments and Related Information

Operating Segments and Related Information

We conduct our operations through the following four reportable segments:

Recovery Audit Services – Americas represents recovery audit services (other than Healthcare Claims Recovery Audit services) provided in the United States of America (“U.S.”), Canada and Latin America.

Recovery Audit Services – Europe/Asia-Pacific represents recovery audit services (other than Healthcare Claims Recovery Audit services) provided in Europe, Asia and the Pacific region.

Adjacent Services represents data transformation, data analytics and associated advisory services.

Healthcare Claims Recovery Audit Services represents recovery audit services for healthcare claims, which consist primarily of services provided under subcontracts related to the Medicare Recovery Audit Contractor program.

Additionally, Corporate Support includes the unallocated portion of corporate selling, general and administrative expenses not specifically attributable to the four reportable segments.

We evaluate the performance of our reportable segments based upon revenue and measures of profit or loss we refer to as EBITDA and Adjusted EBITDA. We define Adjusted EBITDA as earnings from continuing operations before interest and taxes (“EBIT”), adjusted for depreciation and amortization (“EBITDA”), and then further adjusted for unusual and other significant items that management views as distorting the operating results of the various segments from period to period. Such adjustments include restructuring charges, stock-based compensation, bargain purchase gains, acquisition-related charges and benefits (acquisition transaction costs, acquisition obligations classified as compensation, and fair value adjustments to acquisition-related contingent consideration), tangible and intangible asset impairment charges, certain litigation costs and litigation settlements, certain severance charges and foreign currency transaction gains and losses on short-term intercompany balances viewed by management as individually or collectively significant. We do not have any inter-segment revenue.

Segment information for the three months ended March 31, 2015 and 2014 (in thousands) is as follows:

	Recovery Audit Services – Americas		Recovery Audit Services – Europe/Asia- Pacific			Adjacent Services			Healthcare Claims Recovery Audit Services			Corporate Support			Total
Three Months Ended March 31, 2015
Revenue	$	22,417	$	9,305		$	1,263		$	147		$	—		$	33,132
Net loss															$	(2,958	)
Income tax expense															455
Interest expense (income), net															(42		)
EBIT	$	4,078	$	(442	)	$	(885	)	$	(702	)	$	(4,594	)	(2,545		)
Depreciation of property and equipment	969		153			157			13			—			1,292
Amortization of intangible assets	441		273			32			—			—			746
EBITDA	5,488		(16		)	(696		)	(689		)	(4,594		)	(507		)
Foreign currency transaction (gains) losses on short-term intercompany balances	437		1,318			—			—			(63		)	1,692
Transformation severance and related expenses	56		65			16			—			9			146
Stock-based compensation	—		—			—			—			1,132			1,132
Adjusted EBITDA	$	5,981	$	1,367		$	(680	)	$	(689	)	$	(3,516	)	$	2,463

	Recovery Audit Services – Americas		Recovery Audit Services – Europe/Asia- Pacific			Adjacent Services			Healthcare Claims Recovery Audit Services			Corporate Support			Total
Three Months Ended March 31, 2014
Revenue	$	24,798	$	9,702		$	2,283		$	1,118		$	—		$	37,901
Net loss															$	(3,674	)
Income tax expense															113
Interest expense (income), net															54
EBIT	$	4,084	$	101		$	(1,574	)	$	(2,006	)	$	(4,112	)	(3,507		)
Depreciation of property and equipment	1,256		146			160			120			—			1,682
Amortization of intangible assets	500		307			96			—			—			903
EBITDA	5,840		554			(1,318		)	(1,886		)	(4,112		)	(922		)
Foreign currency transaction (gains) losses on short-term intercompany balances	110		(73		)	—			—			(22		)	15
Acquisition-related charges (benefits)	—		—			19			—			—			19
Transformation severance and related expenses	8		79			143			155			—			385
Stock-based compensation	—		—			—			—			1,021			1,021
Adjusted EBITDA	$	5,958	$	560		$	(1,156	)	$	(1,731	)	$	(3,113	)	$	518

XML

Cash and Cash Equivalents (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Line of Credit Facility [Line Items]
Cash and cash equivalents included short-term investments	$ 6.6	$ 12.2
Foreign Banks [Member]
Line of Credit Facility [Line Items]
Cash and cash equivalents included short-term investments	$ 2.9	$ 2.5

XML

Operating Segments and Related Information (Tables)

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Segment information

Segment information for the three months ended March 31, 2015 and 2014 (in thousands) is as follows:

	Recovery Audit Services – Americas		Recovery Audit Services – Europe/Asia- Pacific			Adjacent Services			Healthcare Claims Recovery Audit Services			Corporate Support			Total
Three Months Ended March 31, 2015
Revenue	$	22,417	$	9,305		$	1,263		$	147		$	—		$	33,132
Net loss															$	(2,958	)
Income tax expense															455
Interest expense (income), net															(42		)
EBIT	$	4,078	$	(442	)	$	(885	)	$	(702	)	$	(4,594	)	(2,545		)
Depreciation of property and equipment	969		153			157			13			—			1,292
Amortization of intangible assets	441		273			32			—			—			746
EBITDA	5,488		(16		)	(696		)	(689		)	(4,594		)	(507		)
Foreign currency transaction (gains) losses on short-term intercompany balances	437		1,318			—			—			(63		)	1,692
Transformation severance and related expenses	56		65			16			—			9			146
Stock-based compensation	—		—			—			—			1,132			1,132
Adjusted EBITDA	$	5,981	$	1,367		$	(680	)	$	(689	)	$	(3,516	)	$	2,463

	Recovery Audit Services – Americas		Recovery Audit Services – Europe/Asia- Pacific			Adjacent Services			Healthcare Claims Recovery Audit Services			Corporate Support			Total
Three Months Ended March 31, 2014
Revenue	$	24,798	$	9,702		$	2,283		$	1,118		$	—		$	37,901
Net loss															$	(3,674	)
Income tax expense															113
Interest expense (income), net															54
EBIT	$	4,084	$	101		$	(1,574	)	$	(2,006	)	$	(4,112	)	(3,507		)
Depreciation of property and equipment	1,256		146			160			120			—			1,682
Amortization of intangible assets	500		307			96			—			—			903
EBITDA	5,840		554			(1,318		)	(1,886		)	(4,112		)	(922		)
Foreign currency transaction (gains) losses on short-term intercompany balances	110		(73		)	—			—			(22		)	15
Acquisition-related charges (benefits)	—		—			19			—			—			19
Transformation severance and related expenses	8		79			143			155			—			385
Stock-based compensation	—		—			—			—			1,021			1,021
Adjusted EBITDA	$	5,958	$	560		$	(1,156	)	$	(1,731	)	$	(3,113	)	$	518